Zecotek Photonics Aufträge - 500 Beiträge pro Seite
eröffnet am 25.01.08 09:07:04 von
neuester Beitrag 06.08.08 17:28:44 von
neuester Beitrag 06.08.08 17:28:44 von
Beiträge: 23
ID: 1.137.744
ID: 1.137.744
Aufrufe heute: 0
Gesamt: 27.368
Gesamt: 27.368
Aktive User: 0
ISIN: CA98921P1045 · WKN: A0M8QZ
0,0082
EUR
-10,87 %
-0,0010 EUR
Letzter Kurs 05.12.19 Tradegate
Werte aus der Branche Sonstige Technologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,6050 | +11,01 | |
| 16,800 | +9,09 | |
| 2,5650 | +8,92 | |
| 2,0400 | +6,25 | |
| 1,5800 | +6,04 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,9101 | -9,48 | |
| 2,3000 | -9,80 | |
| 2,7800 | -10,32 | |
| 3,9200 | -23,88 | |
| 1,1520 | -60,72 |
Feedback
Diesen Tread bitte nur für die Aufträge von Zecotek verwenden.Sollte ich einen vergessenbitte nachtragen.
Danke für die Mithilfe
Quelle der Aufträge auf Hompage Zecotek.
University of Geneva to use Zecotek's MAPD Photo Detectors
January 25, 2008
Zecotek Receives MAPD Solid-State Photo Detector Order from the University of Geneva, Switzerland
Vancouver, January 25, 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) today announced that it has received an order for its proprietary Micro-pixel Avalanche Photo Diode (MAPD) solid-state photo detectors from the University of Geneva, Switzerland. The MAPD photo detectors have been selected as an alternative to photo multiplier tubes (PMTs) in the development of new calorimeters for high energy physics. This follows a recent order from the Swiss Institute of High Energy where Zecotek’s MAPD photo detectors will form a critical component in a new, high-performance hadron calorimeter, a device used in key experiments at the European Centre for High Energy Particle Physics (CERN) in Switzerland.
“We are very pleased with the growing interest of the scientific community in our MAPD photo detectors," said Dr. A. F. Zerrouk, Chairman, President and CEO of Zecotek. "We identified high energy physics as one of the important target markets for our MAPDs and these initial sales are validation of both our designs and our market projections. The calorimeter is an essential tool in this area of research, where each device will typically use more than one thousand photo detectors and this is just one of many possible applications in this exciting and high-priority field. Our MAPDs are also currently being evaluated by large medical imaging manufacturers and we are seeing strong interest for many other research and industrial applications.”
Zecotek has developed a compact and cost-effective solid-state photo detector aimed at replacing the bulky and expensive PMTs presently used in a wide range of imaging applications such as PET (positron emission tomography) scanners, gamma cameras and high-energy nuclear physics.
Zecotek`s new MAPDs detect very small signals and are effective for photon counting. They feature extremely high gain, typical of PMTs (~10exp6), with the advantage of low operating voltage (~50 V compared to ~1000 V for PMTs) and their solid-state design makes MAPD photo detectors compact and insensitive to magnetic fields. Zecotek’s MAPD photo detectors also incorporate break-through technology that dramatically improves linearity and allows for very tight timing resolution by providing fast pulse rise time and low jitter. Together with its new LFS scintillation material, Zecotek’s photo detectors provide a powerful platform for new-generation medical imaging applications relying on γ-ray detection, such as PET scanning. Other applications include: confocal microscopy, flow cytometry, DNA sequencing, LIDAR and environmental monitoring, industrial inspection, defense and Homeland security.
January 25, 2008
Zecotek Receives MAPD Solid-State Photo Detector Order from the University of Geneva, Switzerland
Vancouver, January 25, 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) today announced that it has received an order for its proprietary Micro-pixel Avalanche Photo Diode (MAPD) solid-state photo detectors from the University of Geneva, Switzerland. The MAPD photo detectors have been selected as an alternative to photo multiplier tubes (PMTs) in the development of new calorimeters for high energy physics. This follows a recent order from the Swiss Institute of High Energy where Zecotek’s MAPD photo detectors will form a critical component in a new, high-performance hadron calorimeter, a device used in key experiments at the European Centre for High Energy Particle Physics (CERN) in Switzerland.
“We are very pleased with the growing interest of the scientific community in our MAPD photo detectors," said Dr. A. F. Zerrouk, Chairman, President and CEO of Zecotek. "We identified high energy physics as one of the important target markets for our MAPDs and these initial sales are validation of both our designs and our market projections. The calorimeter is an essential tool in this area of research, where each device will typically use more than one thousand photo detectors and this is just one of many possible applications in this exciting and high-priority field. Our MAPDs are also currently being evaluated by large medical imaging manufacturers and we are seeing strong interest for many other research and industrial applications.”
Zecotek has developed a compact and cost-effective solid-state photo detector aimed at replacing the bulky and expensive PMTs presently used in a wide range of imaging applications such as PET (positron emission tomography) scanners, gamma cameras and high-energy nuclear physics.
Zecotek`s new MAPDs detect very small signals and are effective for photon counting. They feature extremely high gain, typical of PMTs (~10exp6), with the advantage of low operating voltage (~50 V compared to ~1000 V for PMTs) and their solid-state design makes MAPD photo detectors compact and insensitive to magnetic fields. Zecotek’s MAPD photo detectors also incorporate break-through technology that dramatically improves linearity and allows for very tight timing resolution by providing fast pulse rise time and low jitter. Together with its new LFS scintillation material, Zecotek’s photo detectors provide a powerful platform for new-generation medical imaging applications relying on γ-ray detection, such as PET scanning. Other applications include: confocal microscopy, flow cytometry, DNA sequencing, LIDAR and environmental monitoring, industrial inspection, defense and Homeland security.
High-Power, High-Resolution Laser Spectrometer Announced
January 22, 2008
Zecotek Announces Official Launch of New High-Power, High-Resolution Laser Spectrometer
Vancouver, January 22, 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) today officially announced the launch of its new computerized, high-power, high-resolution laser spectrometer. The device was specifically developed to meet a rapidly growing demand for higher precision spectrometry in nano- and bio-technological applications. Zecotek’s latest offering pushes the limits of the precise spectral measurements and technological procedures required in these fields. Now in production, the first of the new spectrometers are to be shipped to the Institute for Quantum Computing, University of Waterloo, Canada.
“Our new, fully automated, integrated laser system demonstrates Zecotek’s lead in advanced laser spectrometry.” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “The response from the research community has been excellent. The fundamental laser component implements a proprietary, high-efficiency intra-cavity frequency doubling combined with user friendly control functions, and presents a unique and invaluable new tool for this critical area of research.”
The spectrometer, model TIS/DYE-FD-08/A-scan, incorporates Zecotek’s CW state-of-the-art ultra-wide-tunable laser, which covers a super-broad spectral range between 275 and 1100 nm, with a high-precision wavelength meter and multiple-function electronic control unit. The spectrometer is fully controllable through a high-speed USB 2.0 computer interface running on Windows™ XP/Vista, with a wide range of user-defined settings for scanning, data acquisition and recording. Wavelength selection components and the non-linear crystals are precisely controlled with a wavelength meter and a closed-loop feed-back system.
The spectrometer embodies proprietary Zecotek innovation in the frequency doubling of the fundamental laser and in the tracking and synchronisation of wavelength selectors during wavelength scanning. This tracking removes the requirement for special or additional photo-detectors, which considerably simplifies automatic control and minimises the number of elements requiring active computer control.
Performance parameters include high-power, continuous-wave radiation, both in visible/near IR (up to 4 W), and in blue/UV ranges (up to 0.5 W). The spectrometer provides for a resolution of less than 0.001 nm, supported by the narrow emission line of the base laser source (< 1 GHz) and by the high accuracy of the radiation wavelength meter.
The spectrometer is manufactured for Zecotek Photonics Inc. under contract by Tekhnoscan JSC of Novosibirsk, Russia and distributed through Zecotek Laser Systems Pte Ltd.
January 22, 2008
Zecotek Announces Official Launch of New High-Power, High-Resolution Laser Spectrometer
Vancouver, January 22, 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) today officially announced the launch of its new computerized, high-power, high-resolution laser spectrometer. The device was specifically developed to meet a rapidly growing demand for higher precision spectrometry in nano- and bio-technological applications. Zecotek’s latest offering pushes the limits of the precise spectral measurements and technological procedures required in these fields. Now in production, the first of the new spectrometers are to be shipped to the Institute for Quantum Computing, University of Waterloo, Canada.
“Our new, fully automated, integrated laser system demonstrates Zecotek’s lead in advanced laser spectrometry.” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “The response from the research community has been excellent. The fundamental laser component implements a proprietary, high-efficiency intra-cavity frequency doubling combined with user friendly control functions, and presents a unique and invaluable new tool for this critical area of research.”
The spectrometer, model TIS/DYE-FD-08/A-scan, incorporates Zecotek’s CW state-of-the-art ultra-wide-tunable laser, which covers a super-broad spectral range between 275 and 1100 nm, with a high-precision wavelength meter and multiple-function electronic control unit. The spectrometer is fully controllable through a high-speed USB 2.0 computer interface running on Windows™ XP/Vista, with a wide range of user-defined settings for scanning, data acquisition and recording. Wavelength selection components and the non-linear crystals are precisely controlled with a wavelength meter and a closed-loop feed-back system.
The spectrometer embodies proprietary Zecotek innovation in the frequency doubling of the fundamental laser and in the tracking and synchronisation of wavelength selectors during wavelength scanning. This tracking removes the requirement for special or additional photo-detectors, which considerably simplifies automatic control and minimises the number of elements requiring active computer control.
Performance parameters include high-power, continuous-wave radiation, both in visible/near IR (up to 4 W), and in blue/UV ranges (up to 0.5 W). The spectrometer provides for a resolution of less than 0.001 nm, supported by the narrow emission line of the base laser source (< 1 GHz) and by the high accuracy of the radiation wavelength meter.
The spectrometer is manufactured for Zecotek Photonics Inc. under contract by Tekhnoscan JSC of Novosibirsk, Russia and distributed through Zecotek Laser Systems Pte Ltd.
Paul Scherrer Institute to use Proprietary MAPD Photo Detectors in PET Program
January 10, 2008
Zecotek’s Proprietary MAPD Solid-State Photo Detectors Selected by the Paul Scherrer Institute, Switzerland
Vancouver, January 10 ,2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) today announced that the Swiss-based Paul Scherrer Institute has selected Zecotek’s proprietary Micro-pixel Avalanche Photo Diodes (MAPD) for trials in its next-generation Positron Emission Tomography (PET) medical imaging program. The Paul Scherrer Institute PET program is focused on advancing improvements in sensitivity, spatial resolution and image quality in PET scanners, based on the understanding that advances in PET are driven largely by progress in instrumentation, in particular the performance of scintillation materials, photo-detectors and read-out electronics. Higher resolution PET scanners will provide more detailed diagnoses, result in improved patient outcomes and broaden PET applications in brain function analysis and diagnosis.
“The Paul Scherrer Institute is highly respected for its work in advancing medical imaging and we are delighted they have chosen both our MAPD photo detectors and, as previously announced, LFS scintillation crystal for their PET program,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “The MAPD photo detector and the LFS scintillation material form the core elements of a new class of detector array used in medical imaging. Our detector array offers improved performance at a lower cost and, because our MAPDs are not affected by magnetic fields, offers the potential break-through of an integrated PET-MRI (Magnetic Resonance Imaging) scanning device.”
Zecotek’s MAPD solid-state photo detectors have been designed in several configurations to offer significant performance and cost advantages over the current photo-multiplier vacuum tubes (PMT) and existing solid state photo-detectors. The MAPD-2 addresses specific, high-demand requirements in high-energy physics such as particle accelerators where PMT’s are vulnerable to the magnetic environment created by the superconducting magnets used in the collimation of particle tracks. The MAPD-3 meets required specifications for advanced, high resolution PET scanners and gamma camera applications, particularly when matched with Zecotek’s patented LFS scintillation materials. Photo detectors, together with the scintillation material, typically constitute 50 to 65% of the manufacturing cost of a PET scanner.
The selection of Zecotek’s MAPD photo detectors follows an extensive and competitive program of testing and evaluation. The MAPDs will be supplied through Zecotek Imaging Systems Pte. Ltd., Singapore, a wholly owned subsidiary of Zecotek Photonics Inc., and manufactured under contract by the Malaysian Institute of Microelectronic Systems
January 10, 2008
Zecotek’s Proprietary MAPD Solid-State Photo Detectors Selected by the Paul Scherrer Institute, Switzerland
Vancouver, January 10 ,2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) today announced that the Swiss-based Paul Scherrer Institute has selected Zecotek’s proprietary Micro-pixel Avalanche Photo Diodes (MAPD) for trials in its next-generation Positron Emission Tomography (PET) medical imaging program. The Paul Scherrer Institute PET program is focused on advancing improvements in sensitivity, spatial resolution and image quality in PET scanners, based on the understanding that advances in PET are driven largely by progress in instrumentation, in particular the performance of scintillation materials, photo-detectors and read-out electronics. Higher resolution PET scanners will provide more detailed diagnoses, result in improved patient outcomes and broaden PET applications in brain function analysis and diagnosis.
“The Paul Scherrer Institute is highly respected for its work in advancing medical imaging and we are delighted they have chosen both our MAPD photo detectors and, as previously announced, LFS scintillation crystal for their PET program,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “The MAPD photo detector and the LFS scintillation material form the core elements of a new class of detector array used in medical imaging. Our detector array offers improved performance at a lower cost and, because our MAPDs are not affected by magnetic fields, offers the potential break-through of an integrated PET-MRI (Magnetic Resonance Imaging) scanning device.”
Zecotek’s MAPD solid-state photo detectors have been designed in several configurations to offer significant performance and cost advantages over the current photo-multiplier vacuum tubes (PMT) and existing solid state photo-detectors. The MAPD-2 addresses specific, high-demand requirements in high-energy physics such as particle accelerators where PMT’s are vulnerable to the magnetic environment created by the superconducting magnets used in the collimation of particle tracks. The MAPD-3 meets required specifications for advanced, high resolution PET scanners and gamma camera applications, particularly when matched with Zecotek’s patented LFS scintillation materials. Photo detectors, together with the scintillation material, typically constitute 50 to 65% of the manufacturing cost of a PET scanner.
The selection of Zecotek’s MAPD photo detectors follows an extensive and competitive program of testing and evaluation. The MAPDs will be supplied through Zecotek Imaging Systems Pte. Ltd., Singapore, a wholly owned subsidiary of Zecotek Photonics Inc., and manufactured under contract by the Malaysian Institute of Microelectronic Systems
Institute of High Energy Physics Research Orders MAPD Photo Detectors
December 13, 2007
Zecotek Receives MAPD Solid-State Photo Detector Order From Institute of High Energy Physics Research
Vancouver, December 13, 2007 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), formerly Zecotek Medical Systems Inc., today announced that it has received an order for a supply of its proprietary Micro-pixel Avalanche Photo Diodes (MAPD) solid-state photo detectors from the Institute of High Energy Physics Research (INR). The MAPD photo detectors will form a critical component in a new, high-performance hadron calorimeter, a device used in key experiments at the European Centre for High Energy particle Physics (CERN) in Switzerland.
“We are very pleased that the INR has selected our MAPD as a critical component for their high-performance calorimeter to be used in the prestigious CERN program,” said Dr. A. F. Zerrouk, Chairman, President and CEO of Zecotek. “The INR is a leading and highly respected Institute in the field of particle physics and we believe this type of application should result in significant additional and recurring sales for our MAPDs.”
The hadron calorimeter will be used for the detection of particles in nucleus-nucleus collisions at the energy range from 10 to 160 GeV per nucleon. Each calorimeter will contain of a large number of modules consisting of multiple layers of plastic scintillator material. Light produced by the particles in the scintillator is collected by a wavelength shifting fiber and collected at a MAPD. The MAPD will provide both high pixel density in excess of 10,000 pixels per square mm and required gain.
The INR successfully constructed and tested the first supermodule with MAPDs as a critical component in its CERN labs in Switzerland. Results of the successful application were announced at a recent CERN workshop by the leading researcher, Dr. Fedor Guber.
INR’s first calorimeter will require over one thousand MAPDs which will be supplied through Zecotek Imaging Systems Pte. Ltd., Singapore, a wholly owned subsidiary of Zecotek Photonics Inc. The MAPDs are manufactured under contract by the Malaysian Institute of Microelectronic Systems.
December 13, 2007
Zecotek Receives MAPD Solid-State Photo Detector Order From Institute of High Energy Physics Research
Vancouver, December 13, 2007 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), formerly Zecotek Medical Systems Inc., today announced that it has received an order for a supply of its proprietary Micro-pixel Avalanche Photo Diodes (MAPD) solid-state photo detectors from the Institute of High Energy Physics Research (INR). The MAPD photo detectors will form a critical component in a new, high-performance hadron calorimeter, a device used in key experiments at the European Centre for High Energy particle Physics (CERN) in Switzerland.
“We are very pleased that the INR has selected our MAPD as a critical component for their high-performance calorimeter to be used in the prestigious CERN program,” said Dr. A. F. Zerrouk, Chairman, President and CEO of Zecotek. “The INR is a leading and highly respected Institute in the field of particle physics and we believe this type of application should result in significant additional and recurring sales for our MAPDs.”
The hadron calorimeter will be used for the detection of particles in nucleus-nucleus collisions at the energy range from 10 to 160 GeV per nucleon. Each calorimeter will contain of a large number of modules consisting of multiple layers of plastic scintillator material. Light produced by the particles in the scintillator is collected by a wavelength shifting fiber and collected at a MAPD. The MAPD will provide both high pixel density in excess of 10,000 pixels per square mm and required gain.
The INR successfully constructed and tested the first supermodule with MAPDs as a critical component in its CERN labs in Switzerland. Results of the successful application were announced at a recent CERN workshop by the leading researcher, Dr. Fedor Guber.
INR’s first calorimeter will require over one thousand MAPDs which will be supplied through Zecotek Imaging Systems Pte. Ltd., Singapore, a wholly owned subsidiary of Zecotek Photonics Inc. The MAPDs are manufactured under contract by the Malaysian Institute of Microelectronic Systems.
Trading Spotlight
University of Waterloo Selects New CW Narrow-Band Ti: Sapphire Laser
November 15, 2007
Zecotek's New CW Narrow-Band Ti: Sapphire Laser Selected by University of Waterloo
Vancouver, BC, November 15, 2007 - Zecotek Medical Systems, Inc. (TSX-V: ZMS; Frankfurt: W1I.F) today announced the selection of its CW Ti: Sapphire laser, model TIS-FD-08/A-scan-WV, by the Institute for Quantum Computing, University of Waterloo, Canada. The laser is the latest ultra-wide tunable laser to be developed by Zecotek and will be used by the Institute in the field of nano-optics (the investigation of single semiconductor quantum dots) and quantum computing.
“We are very pleased that the University of Waterloo’s prestigious Institute for Quantum Computing has selected our latest CW Ti: Sapphire laser,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “Our new auto-scanned narrow band Ti: Sapphire laser is a valuable tool in this important area of research and is another example of Zecotek’s strength in the innovation and commercialization of leading edge photonic technologies.”
Zecotek’s CW narrow-band Ti: Sapphire laser, with computer control and integrated wave meter, represents the optimal cost-effective solution for a source of radiation tuneable within a wide range of wavelengths, important features for spectroscopy of semiconductor materials and other advanced material and scientific applications.
Zecotek’s Ti: Sapphire lasers are manufactured under contract by Tekhnoscan Lasers of Novosibirsk, for Zecotek Laser Systems Pte Ltd., the company’s wholly owned subsidiary
November 15, 2007
Zecotek's New CW Narrow-Band Ti: Sapphire Laser Selected by University of Waterloo
Vancouver, BC, November 15, 2007 - Zecotek Medical Systems, Inc. (TSX-V: ZMS; Frankfurt: W1I.F) today announced the selection of its CW Ti: Sapphire laser, model TIS-FD-08/A-scan-WV, by the Institute for Quantum Computing, University of Waterloo, Canada. The laser is the latest ultra-wide tunable laser to be developed by Zecotek and will be used by the Institute in the field of nano-optics (the investigation of single semiconductor quantum dots) and quantum computing.
“We are very pleased that the University of Waterloo’s prestigious Institute for Quantum Computing has selected our latest CW Ti: Sapphire laser,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “Our new auto-scanned narrow band Ti: Sapphire laser is a valuable tool in this important area of research and is another example of Zecotek’s strength in the innovation and commercialization of leading edge photonic technologies.”
Zecotek’s CW narrow-band Ti: Sapphire laser, with computer control and integrated wave meter, represents the optimal cost-effective solution for a source of radiation tuneable within a wide range of wavelengths, important features for spectroscopy of semiconductor materials and other advanced material and scientific applications.
Zecotek’s Ti: Sapphire lasers are manufactured under contract by Tekhnoscan Lasers of Novosibirsk, for Zecotek Laser Systems Pte Ltd., the company’s wholly owned subsidiary
Gwangju Institute of Science and Technology Selects Advanced Dye Laser
November 09, 2007
Zecotek’s Advanced Dye Laser Selected by Gwangju Institute of Science and Technology, Korea
Vancouver, BC, November 9, 2007 - Zecotek Medical Systems, Inc. (TSX-V: ZMS; Frankfurt: W1I.F) today announced the sale of a CW single-frequency ring Dye laser system to Korea’s prestigious Gwangju Institute of Science and Technology (GIST) for high-precision laser spectroscopy in its Advanced Photonics Research Institute. GIST was established in 1993 by the Republic of Korea to meet the nation’s needs for advanced research and to take a leading role in performing research and development with industry sectors.
“We are very pleased that Korea’s prestigious Gwangju Institute of Science and Technology has selected our CW Dye laser for their advanced spectroscopy program, following a highly competitive international selection process,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “This is an excellent endorsement of both the technical superiority and cost effectiveness of our new lines of laser products.”
Zecotek’s frequency-stabilized CW single-frequency ring Dye laser, model DYE-SF-077, is a further development of model DYE-SF-07 which includes a new system of frequency stabilization based on a thermo-stabilized interferometer and a fast electronic driver. This model provides a line width of less than 100 kHz, setting a new standard for commercial dye lasers, where previously the narrowest available line-width was 500 kHz - 1 MHz.
- 30 -
November 09, 2007
Zecotek’s Advanced Dye Laser Selected by Gwangju Institute of Science and Technology, Korea
Vancouver, BC, November 9, 2007 - Zecotek Medical Systems, Inc. (TSX-V: ZMS; Frankfurt: W1I.F) today announced the sale of a CW single-frequency ring Dye laser system to Korea’s prestigious Gwangju Institute of Science and Technology (GIST) for high-precision laser spectroscopy in its Advanced Photonics Research Institute. GIST was established in 1993 by the Republic of Korea to meet the nation’s needs for advanced research and to take a leading role in performing research and development with industry sectors.
“We are very pleased that Korea’s prestigious Gwangju Institute of Science and Technology has selected our CW Dye laser for their advanced spectroscopy program, following a highly competitive international selection process,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “This is an excellent endorsement of both the technical superiority and cost effectiveness of our new lines of laser products.”
Zecotek’s frequency-stabilized CW single-frequency ring Dye laser, model DYE-SF-077, is a further development of model DYE-SF-07 which includes a new system of frequency stabilization based on a thermo-stabilized interferometer and a fast electronic driver. This model provides a line width of less than 100 kHz, setting a new standard for commercial dye lasers, where previously the narrowest available line-width was 500 kHz - 1 MHz.
- 30 -
First Commercial Run of MAPD Solid-State Photo Detectors
October 31, 2007
Zecotek Announces First Commercial Production Run of New-Generation Solid-State Photo Detectors
Vancouver, October 31, 2007 - Zecotek Medical Systems Inc. (TSX-V: ZMS; Frankfurt: W1I.F) today announced that the Malaysian Institute for Micro-electronics Systems (MIMOS), Malaysia’s premier center for advanced micro-electronics technology and manufacturing based in Kuala Lumpur, has successfully completed the first commercial production run of the company’s new-generation Micro-pixel Avalanche Photo Diodes (MAPD) solid-state photo detectors. First-run production samples are being delivered to key customers in both medical imaging and high-energy physics for further testing.
“We are extremely impressed by the production capabilities of MIMOS,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “The first production runs of our MAPD-2 and MAPD-3 were produced with excellent yields and at a cost that gives Zecotek a significant advantage over competing products. We are confident that with its cost and performance advantages, Zecotek’s MAPD will rapidly become the gold standard in photo-detection.”
Zecotek’s patented MAPD’s have been designed in several configurations to offer significant performance and cost advantages over the current photo-multiplier vacuum tubes (PMT) and existing solid state photo-detectors. The MAPD-2 addresses specific, high-demand requirements in high-energy physics such as particle accelerators where PMT’s are vulnerable to the magnetic environment created by the superconducting magnets used in the collimation of particle tracks. The MAPD-3 meets required specifications for advanced, high resolution PET (Positron Emission Tomography) scanners and gamma camera applications, particularly when matched with Zecotek’s patented LFS scintillation materials. Zecotek is focused on bringing to market a cost effective, mass produced MAPD’s with consistent key performance parameters, such as high linearity and timing resolution, essential for “time of flight” design configurations used in next generation, high resolution PET medical scanners.
Pre-production MAPD’s, developed in Zecotek’s own labs, were successfully tested by a number of third-party entities including the University of Washington, which demonstrated that Zecotek’s MAPD’s, in combination with its patented LFS scintillation crystal, outperformed current PMT’s in critical imaging parameters.
“Our laboratory has been using Zecotek’s prototype MAPD-2 and MAPD-3 devices in our designs for high-resolution detectors for pre-clinical positron emission tomography (PET) scanners and a PET insert for magnetic resonance (MRI) scanners,” reported Dr. Thomas Lewellen, Professor of Radiology and Director of Physics and Instrumentation Development in Nuclear Medicine at the University of Washington and a member of Zecotek’s Advisory Board. “We look forward to implementing the improved, production version of the MAPD in our scanning systems. We believe that a solid-state replacement for photomultipliers, such as the MAPD, is essential for a wide range of important detector design advances and for future PET development in particular.”
Most solid state photo-detectors developed in the past few years are generally based on the MAPD-1 design concept, originally developed and patented by Prof. Zair Sadygov, Chief Scientist at Zecotek. Zecotek has built on this design concept and completed the development of the MAPD-2 and MAPD-3, versions which are compatible with large scale manufacture without compromising the operational characteristics requested by the imaging industries.
PMT based photo-detection devices form a major cost component in the US$1 billion market for PET and PET-CT scanners, representing approximately one-third of the cost of each unit. Existing PMT’s are also key components of medical inspection devices used in blood analysis and DNA sequencing. Additional non-medical applications include: gamma ray detectors for homeland security, environmental monitoring, industrial control systems, robotics, biomedical testing, navigation and guidance systems, laser radars and high-energy physics.
The MAPD’s will be made available for sale to qualified customers through the company’s website. Technical information on the MAPD can be found on the company’s website www.zecotek.com/products.
October 31, 2007
Zecotek Announces First Commercial Production Run of New-Generation Solid-State Photo Detectors
Vancouver, October 31, 2007 - Zecotek Medical Systems Inc. (TSX-V: ZMS; Frankfurt: W1I.F) today announced that the Malaysian Institute for Micro-electronics Systems (MIMOS), Malaysia’s premier center for advanced micro-electronics technology and manufacturing based in Kuala Lumpur, has successfully completed the first commercial production run of the company’s new-generation Micro-pixel Avalanche Photo Diodes (MAPD) solid-state photo detectors. First-run production samples are being delivered to key customers in both medical imaging and high-energy physics for further testing.
“We are extremely impressed by the production capabilities of MIMOS,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “The first production runs of our MAPD-2 and MAPD-3 were produced with excellent yields and at a cost that gives Zecotek a significant advantage over competing products. We are confident that with its cost and performance advantages, Zecotek’s MAPD will rapidly become the gold standard in photo-detection.”
Zecotek’s patented MAPD’s have been designed in several configurations to offer significant performance and cost advantages over the current photo-multiplier vacuum tubes (PMT) and existing solid state photo-detectors. The MAPD-2 addresses specific, high-demand requirements in high-energy physics such as particle accelerators where PMT’s are vulnerable to the magnetic environment created by the superconducting magnets used in the collimation of particle tracks. The MAPD-3 meets required specifications for advanced, high resolution PET (Positron Emission Tomography) scanners and gamma camera applications, particularly when matched with Zecotek’s patented LFS scintillation materials. Zecotek is focused on bringing to market a cost effective, mass produced MAPD’s with consistent key performance parameters, such as high linearity and timing resolution, essential for “time of flight” design configurations used in next generation, high resolution PET medical scanners.
Pre-production MAPD’s, developed in Zecotek’s own labs, were successfully tested by a number of third-party entities including the University of Washington, which demonstrated that Zecotek’s MAPD’s, in combination with its patented LFS scintillation crystal, outperformed current PMT’s in critical imaging parameters.
“Our laboratory has been using Zecotek’s prototype MAPD-2 and MAPD-3 devices in our designs for high-resolution detectors for pre-clinical positron emission tomography (PET) scanners and a PET insert for magnetic resonance (MRI) scanners,” reported Dr. Thomas Lewellen, Professor of Radiology and Director of Physics and Instrumentation Development in Nuclear Medicine at the University of Washington and a member of Zecotek’s Advisory Board. “We look forward to implementing the improved, production version of the MAPD in our scanning systems. We believe that a solid-state replacement for photomultipliers, such as the MAPD, is essential for a wide range of important detector design advances and for future PET development in particular.”
Most solid state photo-detectors developed in the past few years are generally based on the MAPD-1 design concept, originally developed and patented by Prof. Zair Sadygov, Chief Scientist at Zecotek. Zecotek has built on this design concept and completed the development of the MAPD-2 and MAPD-3, versions which are compatible with large scale manufacture without compromising the operational characteristics requested by the imaging industries.
PMT based photo-detection devices form a major cost component in the US$1 billion market for PET and PET-CT scanners, representing approximately one-third of the cost of each unit. Existing PMT’s are also key components of medical inspection devices used in blood analysis and DNA sequencing. Additional non-medical applications include: gamma ray detectors for homeland security, environmental monitoring, industrial control systems, robotics, biomedical testing, navigation and guidance systems, laser radars and high-energy physics.
The MAPD’s will be made available for sale to qualified customers through the company’s website. Technical information on the MAPD can be found on the company’s website www.zecotek.com/products.
Zecotek Announces Sale of LFS Scintillation Crystals
October 25, 2007
Zecotek’s Patented LFS Scintillation Crystals Selected for Trials by the Paul Scherrer Institute, Switzerland
Vancouver, October 25, 2007 - Zecotek Medical Systems Inc. (TSX-V: ZMS; Frankfurt: W1I) today announced the Paul Scherrer Institute based in Switzerland has purchased an order of Zecotek’s patented Lutetium Fine Silicate (LFS) scintillation crystals for trials in its next-generation Positron Emission Tomography (PET) medical imaging program. The Paul Scherrer Institute PET program is focused on advancing improvements in sensitivity, spatial resolution and image quality in PET scanners, based on the understanding that advances in PET are driven largely by progress in instrumentation, in particular the performance of scintillation materials, photo-detectors and read-out electronics. Higher resolution PET scanners would also widen PET’s application in brain function analysis and diagnosis.
“We are delighted that the prestigious Paul Scherrer Institute is working with our LFS scintillation crystals in their program to develop a next generation PET detector module,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “The Institute is well known and highly respected for its work in medical imaging and is representative of the broader market for our LFS scintillation crystals.”
Zecotek’s patented LFS scintillation material was developed as a high-performance, cost-effective replacement for the materials used in the present generation of PET machines and other medical and non-medical imaging applications. The LFS crystals also complement Zecotek’s patented Micro-pixel Avalanche Photo Diodes (MAPD), designed to replace current use photo multiplier tube photo detectors. Both Zecotek’s LFS and MAPD offer significant benefits to the diagnostic medical industry. The scintillation material, together with the photo-detector, typically constitutes 50 to 65% of the manufacturing cost of a PET scanner. Both the LFS and MAPD offer increased performance and lowered costs, improving both patient throughput and improved diagnostics in PET and PET-CT (Computed Tomography) applications. The combined use of Zecotek's LFS material and MAPD would also enable an integrated PET-MRI (Magnetic Resonance Imaging) machin
October 25, 2007
Zecotek’s Patented LFS Scintillation Crystals Selected for Trials by the Paul Scherrer Institute, Switzerland
Vancouver, October 25, 2007 - Zecotek Medical Systems Inc. (TSX-V: ZMS; Frankfurt: W1I) today announced the Paul Scherrer Institute based in Switzerland has purchased an order of Zecotek’s patented Lutetium Fine Silicate (LFS) scintillation crystals for trials in its next-generation Positron Emission Tomography (PET) medical imaging program. The Paul Scherrer Institute PET program is focused on advancing improvements in sensitivity, spatial resolution and image quality in PET scanners, based on the understanding that advances in PET are driven largely by progress in instrumentation, in particular the performance of scintillation materials, photo-detectors and read-out electronics. Higher resolution PET scanners would also widen PET’s application in brain function analysis and diagnosis.
“We are delighted that the prestigious Paul Scherrer Institute is working with our LFS scintillation crystals in their program to develop a next generation PET detector module,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “The Institute is well known and highly respected for its work in medical imaging and is representative of the broader market for our LFS scintillation crystals.”
Zecotek’s patented LFS scintillation material was developed as a high-performance, cost-effective replacement for the materials used in the present generation of PET machines and other medical and non-medical imaging applications. The LFS crystals also complement Zecotek’s patented Micro-pixel Avalanche Photo Diodes (MAPD), designed to replace current use photo multiplier tube photo detectors. Both Zecotek’s LFS and MAPD offer significant benefits to the diagnostic medical industry. The scintillation material, together with the photo-detector, typically constitutes 50 to 65% of the manufacturing cost of a PET scanner. Both the LFS and MAPD offer increased performance and lowered costs, improving both patient throughput and improved diagnostics in PET and PET-CT (Computed Tomography) applications. The combined use of Zecotek's LFS material and MAPD would also enable an integrated PET-MRI (Magnetic Resonance Imaging) machin
University of Illinois Buys Laser System
February 28, 2008
University of Illinois Selects Zecotek’s New CW Ti: Sapphire Laser and Frequency Doubling Device for Quantum Physics Project
Vancouver, BC, February 28, 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F) today announced that the Department of Physics at the University of Illinois, Urbana-Champaign, Illinois, U.S.A., has ordered its proprietary TIS-SF-777 Ti: Sapphire laser (Triple Seven laser) and a FD-SE-07 resonant frequency doubler. The tandem device has the ability to deliver a super-narrow line of powerful radiation in the blue spectral range and provides a significant new tool for application in fields such as nanolithography, nanostructured materials and quantum physics where single atoms and ions can now be cooled, trapped, and precisely manipulated using laser beams.
“We are extremely pleased that the University of Illinois at Urbana-Champaign has selected our proprietary Triple Seven laser and resonant frequency doubler for work in the important area of quantum research,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “The Physics Department at the University recognizes that Zecotek has significantly moved the performance criteria for this class of laser device. We are justifiably proud of the expertise and innovation the Triple Seven laser represents as it joins Zecotek’s growing portfolio of leading edge photonic products.”
A key feature of Zecotek’s Triple Seven laser is its super-narrow radiation line width. The device specification provides for an absolute line width of less than 10 kHz rms. However, in performance testing, the absolute width of the output radiation line has been determined at 1 kHz – an exceptional performance parameter for this class of laser. Another key feature of Zecotek’s frequency doubler is its conversion efficiency which, at >25%, also sets a new performance standard for commercial products.
Zecotek’s Ti:Sapphire lasers are manufactured under contract by Tekhnoscan J.S. of Novosibirsk, for Zecotek Laser Systems Pte Ltd, a wholly owned subsidiary of Zecotek Photonics.
February 28, 2008
University of Illinois Selects Zecotek’s New CW Ti: Sapphire Laser and Frequency Doubling Device for Quantum Physics Project
Vancouver, BC, February 28, 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F) today announced that the Department of Physics at the University of Illinois, Urbana-Champaign, Illinois, U.S.A., has ordered its proprietary TIS-SF-777 Ti: Sapphire laser (Triple Seven laser) and a FD-SE-07 resonant frequency doubler. The tandem device has the ability to deliver a super-narrow line of powerful radiation in the blue spectral range and provides a significant new tool for application in fields such as nanolithography, nanostructured materials and quantum physics where single atoms and ions can now be cooled, trapped, and precisely manipulated using laser beams.
“We are extremely pleased that the University of Illinois at Urbana-Champaign has selected our proprietary Triple Seven laser and resonant frequency doubler for work in the important area of quantum research,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “The Physics Department at the University recognizes that Zecotek has significantly moved the performance criteria for this class of laser device. We are justifiably proud of the expertise and innovation the Triple Seven laser represents as it joins Zecotek’s growing portfolio of leading edge photonic products.”
A key feature of Zecotek’s Triple Seven laser is its super-narrow radiation line width. The device specification provides for an absolute line width of less than 10 kHz rms. However, in performance testing, the absolute width of the output radiation line has been determined at 1 kHz – an exceptional performance parameter for this class of laser. Another key feature of Zecotek’s frequency doubler is its conversion efficiency which, at >25%, also sets a new performance standard for commercial products.
Zecotek’s Ti:Sapphire lasers are manufactured under contract by Tekhnoscan J.S. of Novosibirsk, for Zecotek Laser Systems Pte Ltd, a wholly owned subsidiary of Zecotek Photonics.
Zecotek & Fujikura Announce Agreement
February 25, 2008
Zecotek and Fujikura Ltd. of Japan Sign Manufacturing and Commercialization Agreement
Vancouver, February 25, 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) today announced that Zecotek Laser Systems Singapore Pte Ltd., a wholly-owned subsidiary, has signed an agreement with Fujikura Ltd, Japan to develop, manufacture and commercialize Zecotek and Fujikura laser products, associated components and systems, including Zecotek’s crystal and fiber based lasers and Fujikura’s infra-red fiber lasers.
“We are delighted to have reached this important manufacturing and commercialization agreement with Fujikura, one of Japan’s leading high technology companies,” said Dr. Zerrouk, Chairman, President and CEO of Zecotek. “The Fujikura name is well known and highly respected around the world for its sophisticated manufacturing expertise in fiber and photonic systems and components. Our immediate priorities are to begin the transfer to production of Zecotek’s new and unique class of fiber lasers, which have received excellent response from the market, and to establish a joint development program for a next generation of infra-red lasers.”
Under the terms of the agreement, all intellectual property, products and processes in the field of lasers and lasers related fiber technologies will be ‘pooled’ into a joint development, manufacturing and commercializing program. The pool that is created will be for the sole use of the said manufacturing program, with both parties retaining all their respective rights to any and all intellectual property and know-how initially brought into the collaboration. The parties will share in any jointly created intellectual property proportional to their relative contribution. The pool will initially comprise Zecotek’s solid state and fiber based lasers and Fujikura’s newly developed infra-red fiber lasers.
Under the terms of the agreement, the parties have appointed Fujikura as the manufacturer. The agreement also includes a right of first refusal provision for Fujikura to acquire or take another form of equity position in Zecotek Laser Systems with terms to be mutually agreed.
February 25, 2008
Zecotek and Fujikura Ltd. of Japan Sign Manufacturing and Commercialization Agreement
Vancouver, February 25, 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) today announced that Zecotek Laser Systems Singapore Pte Ltd., a wholly-owned subsidiary, has signed an agreement with Fujikura Ltd, Japan to develop, manufacture and commercialize Zecotek and Fujikura laser products, associated components and systems, including Zecotek’s crystal and fiber based lasers and Fujikura’s infra-red fiber lasers.
“We are delighted to have reached this important manufacturing and commercialization agreement with Fujikura, one of Japan’s leading high technology companies,” said Dr. Zerrouk, Chairman, President and CEO of Zecotek. “The Fujikura name is well known and highly respected around the world for its sophisticated manufacturing expertise in fiber and photonic systems and components. Our immediate priorities are to begin the transfer to production of Zecotek’s new and unique class of fiber lasers, which have received excellent response from the market, and to establish a joint development program for a next generation of infra-red lasers.”
Under the terms of the agreement, all intellectual property, products and processes in the field of lasers and lasers related fiber technologies will be ‘pooled’ into a joint development, manufacturing and commercializing program. The pool that is created will be for the sole use of the said manufacturing program, with both parties retaining all their respective rights to any and all intellectual property and know-how initially brought into the collaboration. The parties will share in any jointly created intellectual property proportional to their relative contribution. The pool will initially comprise Zecotek’s solid state and fiber based lasers and Fujikura’s newly developed infra-red fiber lasers.
Under the terms of the agreement, the parties have appointed Fujikura as the manufacturer. The agreement also includes a right of first refusal provision for Fujikura to acquire or take another form of equity position in Zecotek Laser Systems with terms to be mutually agreed.
Zecotek Moves to Commercialize Photonic Technologies
March 13, 2008
Zecotek Photonics Corporate Update
Vancouver, BC, March 13, 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) is pleased to provide a summarized update of the Company’s progress and recent corporate activities as it moves the Company’s portfolio of photonic technologies into production and manufacturing.
“We continue to successfully execute our business strategy of bringing photonic technologies to market through strong industry partnerships,” said Dr. A. F. Zerrouk, Chairman, President and CEO of Zecotek. “In February 2008 we signed a manufacturing, commercialization and joint development agreement with Fujikura Ltd of Japan. By combining Fujikura’s outstanding manufacturing and product engineering capabilities with Zecotek’s strength in innovation, patents and product portfolio, we have created a new world-class laser enterprise with outstanding market potential. Furthermore, we have strengthened our internal marketing programs and have participated in a number of events such as the Photonics West trade show and the IEEE Nuclear Science Symposium, which have noticeably accelerated both inquiries and orders for all of our product lines. Our full range of laser products, high-performance crystals and solid-state photo detectors are meeting and exceeding quality and production parameters with a growing list of key U.S. and European customers. 2008 promises to be an excellent year for Zecotek.”
Zecotek operates three distinct divisions: Laser Systems, Imaging Systems and 3D Display Systems and develops leading-edge enabling photonic technology and products: laser systems and component, advanced crystals, solid-state photo detectors and other imaging and 3D display technologies, which address central needs in the major markets of material processing,bio-science high- energy, new materials, research, multimedia and security. The Company has labs located in Canada, the United States, Singapore, Malaysia and Russia with its main in-house production facilities in Singapore and Novosibirsk, Russia. Zecotek has outsourced high-volume product manufacturing through strategic alliances with leading industry partners: Northrop Grumman (U.S.A) for Zecotek’s patented LFS scintiallation material, Fujikura Ltd. (Japan) for fiber and solid-state laser systems, Malaysian Institute of Microelectronics (Malaysia) for the solid-state MAPD photo detectors and Anteryon BV (Netherlands) for a key component of the 3D display screen.
March 13, 2008
Zecotek Photonics Corporate Update
Vancouver, BC, March 13, 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) is pleased to provide a summarized update of the Company’s progress and recent corporate activities as it moves the Company’s portfolio of photonic technologies into production and manufacturing.
“We continue to successfully execute our business strategy of bringing photonic technologies to market through strong industry partnerships,” said Dr. A. F. Zerrouk, Chairman, President and CEO of Zecotek. “In February 2008 we signed a manufacturing, commercialization and joint development agreement with Fujikura Ltd of Japan. By combining Fujikura’s outstanding manufacturing and product engineering capabilities with Zecotek’s strength in innovation, patents and product portfolio, we have created a new world-class laser enterprise with outstanding market potential. Furthermore, we have strengthened our internal marketing programs and have participated in a number of events such as the Photonics West trade show and the IEEE Nuclear Science Symposium, which have noticeably accelerated both inquiries and orders for all of our product lines. Our full range of laser products, high-performance crystals and solid-state photo detectors are meeting and exceeding quality and production parameters with a growing list of key U.S. and European customers. 2008 promises to be an excellent year for Zecotek.”
Zecotek operates three distinct divisions: Laser Systems, Imaging Systems and 3D Display Systems and develops leading-edge enabling photonic technology and products: laser systems and component, advanced crystals, solid-state photo detectors and other imaging and 3D display technologies, which address central needs in the major markets of material processing,bio-science high- energy, new materials, research, multimedia and security. The Company has labs located in Canada, the United States, Singapore, Malaysia and Russia with its main in-house production facilities in Singapore and Novosibirsk, Russia. Zecotek has outsourced high-volume product manufacturing through strategic alliances with leading industry partners: Northrop Grumman (U.S.A) for Zecotek’s patented LFS scintiallation material, Fujikura Ltd. (Japan) for fiber and solid-state laser systems, Malaysian Institute of Microelectronics (Malaysia) for the solid-state MAPD photo detectors and Anteryon BV (Netherlands) for a key component of the 3D display screen.
18.03.2008 09:22
IRW-News: Zecotek Photonics Inc.
IRW-PRESS: Zecotek Photonics Inc (News) .: Zecotek vor Kommerzialisierung von Photonik-Technologien
Zecotek vor Kommerzialisierung von Photonik-Technologien
Vancouver, BC, 13. März 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) freut sich, angesichts der bevorstehenden Produktion und Herstellung von Photonik-Technologien eine Zusammenfassung der Fortschritte und jüngsten Aktivitäten des Unternehmens bekannt zu geben.
Wir verfolgen weiterhin unsere erfolgreiche Geschäftsstrategie und bringen durch starke Industriepartnerschaften Photonik-Technologien auf den Markt, sagte Dr. A. F. Zerrouk, Chairman, President und CEO von Zecotek. Im Februar 2008 unterzeichneten wir ein Herstellungs-, Kommerzialisierungs- und gemeinsames Entwicklungsabkommen mit Fujikura Ltd. aus Japan. Durch die Vereinigung von Fujikuras großartiger technischer Fähigkeiten bei der Herstellung und Produktion mit Zecoteks starkem Innovations-, Patent- und Produktportfolio haben wir ein neues erstklassiges Laser-Unternehmen mit hervorragendem Marktpotenzial ins Leben gerufen. Des Weiteren haben wir unsere internen Marketingprogramme verbessert und an einer Reihe von Veranstaltungen teilgenommen, wie etwa an der Messe Photonics West und am IEEE Nuclear Science Symposium, die sowohl die Anfragen als auch die Bestellungen unserer Produktreihe beträchtlich gesteigert haben. Unser gesamtes Sortiment an Laserprodukten, Hochleistungskristallen und Festkörper-Photodetektoren entsprechen den Qualitäts- und Produktionsparametern und übersteigen diese sogar mit einer Vielzahl an neuen US-amerikanischen und europäischen Kunden. 2008 verspricht ein viel versprechendes Jahr für Zecotek zu werden.
Zecotek ist in drei unterschiedlichen Bereichen tätig: Lasersysteme, Bildverarbeitungssysteme und 3D-Darstellungssysteme. Das Unternehmen entwickelt zudem hochmoderne Photonik-Technologien und -Produkte: Lasersysteme und -komponenten, moderne Kristalle, Festkörper-Photodetektoren und andere Bildverarbeitungs- und 3D-Darstellungstechnologien, die sich an die wesentlichen Anforderungen der größeren Märkte der Materialverarbeitung, Biowissenschaft, neuen Materialien, Forschung, Multimedia und Sicherheit richten. Das Unternehmen verfügt über Labors in Kanada, den Vereinigten Staaten, Singapur, Malaysia und Russland; die Haupteinrichtungen der In-House-Produktion befinden sich in Singapur und in Novosibirsk, Russland. Zecotek lagerte die umfangreiche Produktherstellung durch strategische Allianzen mit führenden Industriepartnern aus: Northrop Grumman (USA) für Zecoteks patentiertes LFS -Szintillationsmaterial, Fujikura Ltd. (Japan) für Fiber- und Fest-Lasersysteme, Malaysian Institute of Microelectronics (Malaysia) für die MAPD-Photodetektoren und Anteryon BV (Niederlande) für eine wichtige Komponente des 3D-Darstellungsbildschirms.
Lasersysteme
Durch das vor kurzem gemeldete Herstellungs- und Vertriebsabkommen mit Fujikura Ltd. aus Japan ist Zecotek nun in der Lage, zu einem führenden Anbieter der globalen Lasersystem- und -komponentenbranche zu werden. Der Schwerpunkt der Zusammenarbeit wir auf der Produktion von Zecoteks eigenem Green-Fiber-Laser liegen, wobei die Genomforschung und der gemeinsame sichtbare Fiber-Laser von Zecotek/Fujikura bei der Laserbearbeitung Priorität haben. Beide Unternehmen werden ihre Ressourcen vereinen, um neue Serien von Lasern mit sichtbarer Wellenlänge für bedeutende Märkte im Bereich der Bioinstrumentalisierung herzustellen und um eine Vielzahl an industriellen, kundenbasierten und Forschungsmaterialien zu verarbeiten. Die starke Präsenz und der renommierte Markenname von Fujikura wird uns dabei helfen, auch auf den japanischen und asiatischen Märkten Fuß zu fassen, während Zecotek das Unternehmen Market Tech U.S.A. für einen nicht exklusiven Vertrieb in Nordamerika engagiert.
In den vergangenen Monaten konnte Zecotek seine Verkaufs- und Marketing-Aktivitäten beträchtlich erhöhen, was ebenso wie die Teilnahme an wichtigen Messen zu einer Steigerung der Anfragen und Bestellungen einer Vielzahl an Lasersystemen und -komponenten führte. Die Einnahmen steigen, und das Unternehmen möchte auf seinen jüngsten Verkaufserfolgen aufbauen und führende Forschungs- und Entwicklungseinrichtungen beliefern:
- die physikalische Abteilung der Universität Illinois, Urbana-Champaign, USA - das Institut für Quantenberechnung, Universität Waterloo, Kanada - das renommierte Gwangju Wissenschafts- und Technologieinstitut in Korea - das Nationale Gesundheitsinstitut der USA
Laserkomponenten
Im zweiten Quartal des Geschäftsjahres 2008 begannen die Kristallzüchtungseinrichtungen von Zecotek in Singapur mit der Produktion seiner eigenen Hochleistungs-Rare-Earth-Fine-Oxid- (RFO)-Vanadatkristalle. Als wichtige Komponente bei Festkörper-Laser stellen RFO-Vanadatkristalle die nächste Generation nach den YAG-Kristallen dar, die zurzeit bei etwa 60% aller Laserkristallanwendungen verwendet werden. Die Lasersysteme von Zecotek ermöglichen auch das Schneiden, das Polieren und die Beschichtung des Endkristallproduktes.
Der RFO-Vanadatkristall von Zecotek ist konkurrierenden Produkten sowohl kosten- als auch leistungsmäßig weit voraus. Erste Bestellungen des Hochleistungskristalls wurden bereits an größere Laser-Unternehmen ausgeliefert. Zecotek erweitert seine Produktionseinrichtungen, um den steigenden Bedarf auf dem bestehenden Laser-Markt decken zu können.
Bildverarbeitungssysteme
Zecotek entwickelte mit großem Erfolg zwei wichtige Photonik-Technologien für den Einsatz bei einer Vielzahl an medizinischen und nicht medizinischen Anwendungen: die Lutetium-Fine-Silicate- (LFS)-Szintillationskristalle und eine neue Generation von MAPD-Festkörper-Photodetektoren.
Das Unternehmen legte durch Partnerschaften mit Northrop Grumman Corporation und dem Malaysian Institute for Micro-electronics Systems sowohl für die LFS-Szintillationskristalle als auch für die MAPD-Photodetektoren die Herstellungs- und Produktionskapazität fest. Erste Produktbestellungen für die Szintillationskristalle und Photodetektoren wurden bereits an eine wachsende Anzahl renommierter wissenschaftlicher Einrichtungen ausgeliefert:
- Paul-Scherrer-Institut, Schweiz, verwendet sowohl LFS-Szintillationskristalle als auch MAPD-Photodetektoren bei der nächsten Generation seines medizinischen Positronen-Emissions-Tomographie- (PET)-Bildverarbeitungsprogrammes. - Das Institut für Energie- und Physikforschung, Russland, verwendet MAPD-Photodetektoren des Unternehmens bei einem neuen Hochleistungs-Hadron -Kalorimeter, das bei wichtigen Experimenten im European Centre for High Energy Particle Physics (CERN) in der Schweiz Anwendung findet. - Die Universität Genf, Schweiz, entschied sich bei der Entwicklung neuer Kalorimeter für die MAPD-Photodetektoren von Zecotek als Alternative zu den Photo-Multiplier-Tubes (PMTs).
Der LFS-Szintillationskristall und der MAPD-Photodetektor weisen im Vergleich zu den bestehenden Technologien, die in einer Vielzahl an biomedizinischen, industriellen und Hochenergieanwendungen eingesetzt werden, bedeutende Leistungs- und Kostenvorteile auf.
Zecotek teilt seine Leistungsdaten und unterhält Geschäftsbeziehungen zu wichtigen PET-Geräteherstellern in der Entwicklung von PET -Bildverarbeitungsprogrammen der nächsten Generation. Um seine Position als führender Technologieanbieter der medizinischen Bildverarbeitungsbranche zu untermauern, führt Zecotek mit der Universität Washington ein gemeinsames Forschungsprogramm für die Entwicklung eines eigenen PET-MRI-Detektors als Kerntechnologie einer neuen Generation von medizinischen Bildverarbeitungssystemen durch. Das größte Hindernis eines kombinierten PET- und MRI-Scangerätes sind die starken Magnetfelder von MRI, die die Photodetektionsfähigkeiten der aktuellen PET-Scangeräte zunichte machen. Im Gegensatz zu den vakuumröhrenbasierten PMTs können die MAPD-Photodetektoren von Zecotek auch im hochmagnetischen Umfeld des MRI arbeiten. Aus diesem Grund sind die LFS-Szintillationskristalle und die MAPD-Photodetektoren bei der Entwicklung von Technologien für eine erfolgreiche Kombination von PET und MRI in einem einzigen Gerät von besonders großer Bedeutung. Dieses hochmoderne Gerät bietet sowohl eine höhere Auflösung als auch einen schnelleren Patientendurchsatz, was wiederum die Patientendiagnose verbessert und die Kosten der medizinischen Versorgung verringert.
3D-Darstellungssysteme
Zecotek präsentierte einen voll funktionsfähigen kommerziellen 32-Prototyp seines eigenen Real-Time 3D2D Display Systems©, der ersten 3D-Darstellung, die mehreren Betrachtern eine echte volumetrische Darstellung bietet, während die Tiefe und die Parallaxe über einen breiten Blickwinkel dargestellt werden. Die Präsentation wurde in den unternehmenseigenen Labors in Vancouver vor einer ausgewählten Gruppe von Vertretern potenzieller Industriepartner durchgeführt. Anteryon BV aus den Niederlanden produzieren die unternehmenseigene linsenförmige 3D-Anzeige im 32-Bildschirmformat, was als optimale Größe für die Demonstration seines Leistungspotenzial gilt. Insight Media, ein führendes Verlags- und Beratungsunternehmen, dessen Schwerpunkt auf der Darstellungsbranche liegt, steht dem Unternehmen bezüglich einer Markteinführungsstrategie des Darstellungssystems zur Seite.
Das Real-Time 3D2D Display ist ein neuartiges Darstellungssystem für die Darstellung von Bildern und Daten. Es basiert auf dem Prinzip der Autostereoskopie, stellt jedoch durch seine zum Patent angemeldete Innovation eine neue Generation der 3D-Darstellung dar. Das Design ermöglicht mehrere Benutzer, mehrere Ansichten, Bewegungsfreiheit, hohe Auflösung sowohl im 3D- als auch im 2D-Modus, höhere Bilddynamik im 2D-Modus, gleichzeitige 2D- und 3D-Darstellung, gewöhnliche Helligkeit und Kompatibilität mit bestehenden Anwendungen und ist zudem äußerst kostengünstig.
Forschungs- und Entwicklungsprogramme von Zecotek
- Neues Szintillationsmaterial für die medizinische Bildverarbeitung als eventuelles Nachfolgematerial von LFS; - Ermöglichung von Technologien für kombinierte PET-MRI-Detektoren, die gemeinsam mit der Universität Washington entwickelt werden; - Mehrere Festkörper-Fiber-Laser, einschließlich eines Festkörper-Lasers für die Bioinstrumentation; - Wellenleiter-Mikro-Laser-Technologie, die zurzeit gemeinsam mit der Universität British Columbia entwickelt wird; - 3D-Autostereoskopanzeige in Echtzeit.
Zusammenfassung der Zecotek-Produkte
- Wachsendes Portfolio an Lasersystemen und -komponenten: - Green Fiber Laser, Modell GLF-540-0.2; - SL 1.4 Fiber Coupled Laser; - CW Narrow-Band Ti: Saphir-Laser, Modell TIS-FD-08/A-scan-WV; - CW Single-Frequency Ti: Saphir-Laser, Modell TIS-SF-878; - CW Single Frequency Ring Dye Laser; - TIS/DYE-FD-08/A-scan leistungsstarkes, hochauflösendes Laser-Spektrometer. - Eigentum der RFO-Vanadatkristalle. - Patentierte LFS-Szintillationskristalle. - Zum Patent angemeldete MAPD-Festkörper-Photonenzähler.
Unternehmensaktivitäten
Im Dezember 2007 führte das Unternehmen eine Finanzierung über Eigenkapital durch und erhielt Bruttoeinnahmen in Höhe von C$ 3,4 Millionen (mehrere Einrichtungen). Die Finanzierung wird als Betriebskapital und für die laufenden Projekte, die zurzeit bei den Standorten in Singapur, Malaysia und Vancouver im Gange sind, verwendet: Abschluss der kommerziellen Produktion des MAPD-Festkörper-Photodetektors von Zecotek, Deckung des steigenden Bedarfs an Fiber- und Festkörper-Lasern des Unternehmens, Beginn der kommerziellen Produktion des RFO-Vanadat-Hochleistungslaserkristalls und Festlegung einer strategischen Herstellungs- und Vertriebspartnerschaft für das 3D-Darstellungssystem des Unternehmens.
Der größte Teil der Forschung und Entwicklung ist abgeschlossen, wir konzentrieren uns nun auf die Kommerzialisierung unserer Technologien, sagte Dr. Zerrouk. Wir haben mit Fujikura, Northrop Grumman und dem Malaysian Institute for Micro-electronics Systems wichtige strategische Partner gewonnen und sind somit bestens gerüstet für eine kommerzielle Produktion. Unsere Photonik-Technologien erweckten das Interesse von äußerst renommierten wissenschaftlichen Organisationen, und auch der Absatz steigt. Wir konzentrieren uns weiterhin auf die Umsetzung unseres Geschäftsplanes sowie auf die Steigerung des Aktienwertes und bedanken uns bei unseren Aktionären für ihre Unterstützung.
IRW-News: Zecotek Photonics Inc.
IRW-PRESS: Zecotek Photonics Inc (News) .: Zecotek vor Kommerzialisierung von Photonik-Technologien
Zecotek vor Kommerzialisierung von Photonik-Technologien
Vancouver, BC, 13. März 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) freut sich, angesichts der bevorstehenden Produktion und Herstellung von Photonik-Technologien eine Zusammenfassung der Fortschritte und jüngsten Aktivitäten des Unternehmens bekannt zu geben.
Wir verfolgen weiterhin unsere erfolgreiche Geschäftsstrategie und bringen durch starke Industriepartnerschaften Photonik-Technologien auf den Markt, sagte Dr. A. F. Zerrouk, Chairman, President und CEO von Zecotek. Im Februar 2008 unterzeichneten wir ein Herstellungs-, Kommerzialisierungs- und gemeinsames Entwicklungsabkommen mit Fujikura Ltd. aus Japan. Durch die Vereinigung von Fujikuras großartiger technischer Fähigkeiten bei der Herstellung und Produktion mit Zecoteks starkem Innovations-, Patent- und Produktportfolio haben wir ein neues erstklassiges Laser-Unternehmen mit hervorragendem Marktpotenzial ins Leben gerufen. Des Weiteren haben wir unsere internen Marketingprogramme verbessert und an einer Reihe von Veranstaltungen teilgenommen, wie etwa an der Messe Photonics West und am IEEE Nuclear Science Symposium, die sowohl die Anfragen als auch die Bestellungen unserer Produktreihe beträchtlich gesteigert haben. Unser gesamtes Sortiment an Laserprodukten, Hochleistungskristallen und Festkörper-Photodetektoren entsprechen den Qualitäts- und Produktionsparametern und übersteigen diese sogar mit einer Vielzahl an neuen US-amerikanischen und europäischen Kunden. 2008 verspricht ein viel versprechendes Jahr für Zecotek zu werden.
Zecotek ist in drei unterschiedlichen Bereichen tätig: Lasersysteme, Bildverarbeitungssysteme und 3D-Darstellungssysteme. Das Unternehmen entwickelt zudem hochmoderne Photonik-Technologien und -Produkte: Lasersysteme und -komponenten, moderne Kristalle, Festkörper-Photodetektoren und andere Bildverarbeitungs- und 3D-Darstellungstechnologien, die sich an die wesentlichen Anforderungen der größeren Märkte der Materialverarbeitung, Biowissenschaft, neuen Materialien, Forschung, Multimedia und Sicherheit richten. Das Unternehmen verfügt über Labors in Kanada, den Vereinigten Staaten, Singapur, Malaysia und Russland; die Haupteinrichtungen der In-House-Produktion befinden sich in Singapur und in Novosibirsk, Russland. Zecotek lagerte die umfangreiche Produktherstellung durch strategische Allianzen mit führenden Industriepartnern aus: Northrop Grumman (USA) für Zecoteks patentiertes LFS -Szintillationsmaterial, Fujikura Ltd. (Japan) für Fiber- und Fest-Lasersysteme, Malaysian Institute of Microelectronics (Malaysia) für die MAPD-Photodetektoren und Anteryon BV (Niederlande) für eine wichtige Komponente des 3D-Darstellungsbildschirms.
Lasersysteme
Durch das vor kurzem gemeldete Herstellungs- und Vertriebsabkommen mit Fujikura Ltd. aus Japan ist Zecotek nun in der Lage, zu einem führenden Anbieter der globalen Lasersystem- und -komponentenbranche zu werden. Der Schwerpunkt der Zusammenarbeit wir auf der Produktion von Zecoteks eigenem Green-Fiber-Laser liegen, wobei die Genomforschung und der gemeinsame sichtbare Fiber-Laser von Zecotek/Fujikura bei der Laserbearbeitung Priorität haben. Beide Unternehmen werden ihre Ressourcen vereinen, um neue Serien von Lasern mit sichtbarer Wellenlänge für bedeutende Märkte im Bereich der Bioinstrumentalisierung herzustellen und um eine Vielzahl an industriellen, kundenbasierten und Forschungsmaterialien zu verarbeiten. Die starke Präsenz und der renommierte Markenname von Fujikura wird uns dabei helfen, auch auf den japanischen und asiatischen Märkten Fuß zu fassen, während Zecotek das Unternehmen Market Tech U.S.A. für einen nicht exklusiven Vertrieb in Nordamerika engagiert.
In den vergangenen Monaten konnte Zecotek seine Verkaufs- und Marketing-Aktivitäten beträchtlich erhöhen, was ebenso wie die Teilnahme an wichtigen Messen zu einer Steigerung der Anfragen und Bestellungen einer Vielzahl an Lasersystemen und -komponenten führte. Die Einnahmen steigen, und das Unternehmen möchte auf seinen jüngsten Verkaufserfolgen aufbauen und führende Forschungs- und Entwicklungseinrichtungen beliefern:
- die physikalische Abteilung der Universität Illinois, Urbana-Champaign, USA - das Institut für Quantenberechnung, Universität Waterloo, Kanada - das renommierte Gwangju Wissenschafts- und Technologieinstitut in Korea - das Nationale Gesundheitsinstitut der USA
Laserkomponenten
Im zweiten Quartal des Geschäftsjahres 2008 begannen die Kristallzüchtungseinrichtungen von Zecotek in Singapur mit der Produktion seiner eigenen Hochleistungs-Rare-Earth-Fine-Oxid- (RFO)-Vanadatkristalle. Als wichtige Komponente bei Festkörper-Laser stellen RFO-Vanadatkristalle die nächste Generation nach den YAG-Kristallen dar, die zurzeit bei etwa 60% aller Laserkristallanwendungen verwendet werden. Die Lasersysteme von Zecotek ermöglichen auch das Schneiden, das Polieren und die Beschichtung des Endkristallproduktes.
Der RFO-Vanadatkristall von Zecotek ist konkurrierenden Produkten sowohl kosten- als auch leistungsmäßig weit voraus. Erste Bestellungen des Hochleistungskristalls wurden bereits an größere Laser-Unternehmen ausgeliefert. Zecotek erweitert seine Produktionseinrichtungen, um den steigenden Bedarf auf dem bestehenden Laser-Markt decken zu können.
Bildverarbeitungssysteme
Zecotek entwickelte mit großem Erfolg zwei wichtige Photonik-Technologien für den Einsatz bei einer Vielzahl an medizinischen und nicht medizinischen Anwendungen: die Lutetium-Fine-Silicate- (LFS)-Szintillationskristalle und eine neue Generation von MAPD-Festkörper-Photodetektoren.
Das Unternehmen legte durch Partnerschaften mit Northrop Grumman Corporation und dem Malaysian Institute for Micro-electronics Systems sowohl für die LFS-Szintillationskristalle als auch für die MAPD-Photodetektoren die Herstellungs- und Produktionskapazität fest. Erste Produktbestellungen für die Szintillationskristalle und Photodetektoren wurden bereits an eine wachsende Anzahl renommierter wissenschaftlicher Einrichtungen ausgeliefert:
- Paul-Scherrer-Institut, Schweiz, verwendet sowohl LFS-Szintillationskristalle als auch MAPD-Photodetektoren bei der nächsten Generation seines medizinischen Positronen-Emissions-Tomographie- (PET)-Bildverarbeitungsprogrammes. - Das Institut für Energie- und Physikforschung, Russland, verwendet MAPD-Photodetektoren des Unternehmens bei einem neuen Hochleistungs-Hadron -Kalorimeter, das bei wichtigen Experimenten im European Centre for High Energy Particle Physics (CERN) in der Schweiz Anwendung findet. - Die Universität Genf, Schweiz, entschied sich bei der Entwicklung neuer Kalorimeter für die MAPD-Photodetektoren von Zecotek als Alternative zu den Photo-Multiplier-Tubes (PMTs).
Der LFS-Szintillationskristall und der MAPD-Photodetektor weisen im Vergleich zu den bestehenden Technologien, die in einer Vielzahl an biomedizinischen, industriellen und Hochenergieanwendungen eingesetzt werden, bedeutende Leistungs- und Kostenvorteile auf.
Zecotek teilt seine Leistungsdaten und unterhält Geschäftsbeziehungen zu wichtigen PET-Geräteherstellern in der Entwicklung von PET -Bildverarbeitungsprogrammen der nächsten Generation. Um seine Position als führender Technologieanbieter der medizinischen Bildverarbeitungsbranche zu untermauern, führt Zecotek mit der Universität Washington ein gemeinsames Forschungsprogramm für die Entwicklung eines eigenen PET-MRI-Detektors als Kerntechnologie einer neuen Generation von medizinischen Bildverarbeitungssystemen durch. Das größte Hindernis eines kombinierten PET- und MRI-Scangerätes sind die starken Magnetfelder von MRI, die die Photodetektionsfähigkeiten der aktuellen PET-Scangeräte zunichte machen. Im Gegensatz zu den vakuumröhrenbasierten PMTs können die MAPD-Photodetektoren von Zecotek auch im hochmagnetischen Umfeld des MRI arbeiten. Aus diesem Grund sind die LFS-Szintillationskristalle und die MAPD-Photodetektoren bei der Entwicklung von Technologien für eine erfolgreiche Kombination von PET und MRI in einem einzigen Gerät von besonders großer Bedeutung. Dieses hochmoderne Gerät bietet sowohl eine höhere Auflösung als auch einen schnelleren Patientendurchsatz, was wiederum die Patientendiagnose verbessert und die Kosten der medizinischen Versorgung verringert.
3D-Darstellungssysteme
Zecotek präsentierte einen voll funktionsfähigen kommerziellen 32-Prototyp seines eigenen Real-Time 3D2D Display Systems©, der ersten 3D-Darstellung, die mehreren Betrachtern eine echte volumetrische Darstellung bietet, während die Tiefe und die Parallaxe über einen breiten Blickwinkel dargestellt werden. Die Präsentation wurde in den unternehmenseigenen Labors in Vancouver vor einer ausgewählten Gruppe von Vertretern potenzieller Industriepartner durchgeführt. Anteryon BV aus den Niederlanden produzieren die unternehmenseigene linsenförmige 3D-Anzeige im 32-Bildschirmformat, was als optimale Größe für die Demonstration seines Leistungspotenzial gilt. Insight Media, ein führendes Verlags- und Beratungsunternehmen, dessen Schwerpunkt auf der Darstellungsbranche liegt, steht dem Unternehmen bezüglich einer Markteinführungsstrategie des Darstellungssystems zur Seite.
Das Real-Time 3D2D Display ist ein neuartiges Darstellungssystem für die Darstellung von Bildern und Daten. Es basiert auf dem Prinzip der Autostereoskopie, stellt jedoch durch seine zum Patent angemeldete Innovation eine neue Generation der 3D-Darstellung dar. Das Design ermöglicht mehrere Benutzer, mehrere Ansichten, Bewegungsfreiheit, hohe Auflösung sowohl im 3D- als auch im 2D-Modus, höhere Bilddynamik im 2D-Modus, gleichzeitige 2D- und 3D-Darstellung, gewöhnliche Helligkeit und Kompatibilität mit bestehenden Anwendungen und ist zudem äußerst kostengünstig.
Forschungs- und Entwicklungsprogramme von Zecotek
- Neues Szintillationsmaterial für die medizinische Bildverarbeitung als eventuelles Nachfolgematerial von LFS; - Ermöglichung von Technologien für kombinierte PET-MRI-Detektoren, die gemeinsam mit der Universität Washington entwickelt werden; - Mehrere Festkörper-Fiber-Laser, einschließlich eines Festkörper-Lasers für die Bioinstrumentation; - Wellenleiter-Mikro-Laser-Technologie, die zurzeit gemeinsam mit der Universität British Columbia entwickelt wird; - 3D-Autostereoskopanzeige in Echtzeit.
Zusammenfassung der Zecotek-Produkte
- Wachsendes Portfolio an Lasersystemen und -komponenten: - Green Fiber Laser, Modell GLF-540-0.2; - SL 1.4 Fiber Coupled Laser; - CW Narrow-Band Ti: Saphir-Laser, Modell TIS-FD-08/A-scan-WV; - CW Single-Frequency Ti: Saphir-Laser, Modell TIS-SF-878; - CW Single Frequency Ring Dye Laser; - TIS/DYE-FD-08/A-scan leistungsstarkes, hochauflösendes Laser-Spektrometer. - Eigentum der RFO-Vanadatkristalle. - Patentierte LFS-Szintillationskristalle. - Zum Patent angemeldete MAPD-Festkörper-Photonenzähler.
Unternehmensaktivitäten
Im Dezember 2007 führte das Unternehmen eine Finanzierung über Eigenkapital durch und erhielt Bruttoeinnahmen in Höhe von C$ 3,4 Millionen (mehrere Einrichtungen). Die Finanzierung wird als Betriebskapital und für die laufenden Projekte, die zurzeit bei den Standorten in Singapur, Malaysia und Vancouver im Gange sind, verwendet: Abschluss der kommerziellen Produktion des MAPD-Festkörper-Photodetektors von Zecotek, Deckung des steigenden Bedarfs an Fiber- und Festkörper-Lasern des Unternehmens, Beginn der kommerziellen Produktion des RFO-Vanadat-Hochleistungslaserkristalls und Festlegung einer strategischen Herstellungs- und Vertriebspartnerschaft für das 3D-Darstellungssystem des Unternehmens.
Der größte Teil der Forschung und Entwicklung ist abgeschlossen, wir konzentrieren uns nun auf die Kommerzialisierung unserer Technologien, sagte Dr. Zerrouk. Wir haben mit Fujikura, Northrop Grumman und dem Malaysian Institute for Micro-electronics Systems wichtige strategische Partner gewonnen und sind somit bestens gerüstet für eine kommerzielle Produktion. Unsere Photonik-Technologien erweckten das Interesse von äußerst renommierten wissenschaftlichen Organisationen, und auch der Absatz steigt. Wir konzentrieren uns weiterhin auf die Umsetzung unseres Geschäftsplanes sowie auf die Steigerung des Aktienwertes und bedanken uns bei unseren Aktionären für ihre Unterstützung.
: Zecotek Photonics Inc.
Zecotek Receives Russian Patent for MAPD Solid-State Photo Detectors; U.S. and PCT Patents Pending
VANCOUVER, British Columbia, March 28, 2008 (PRIME NEWSWIRE) -- Zecotek Photonics Inc. (TSX-V:ZMS) (Frankfurt:W1I) today announced that it has been granted full patent rights for its latest Micro-channel Avalanche Photodiode solid-state photo detector by the Agency for Intellectual Property Protection in Russia. Zecotek currently has pending U.S. and PCT (Patent Cooperation Treaty) counterpart applications for worldwide patent rights and anticipates approvals.
"Russia is acknowledged as the leader in the field of photo detection and the granting of Russian patent rights fully endorses the technological breakthroughs we have achieved," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. "Of equal importance is the demonstration of the MAPD's commercial viability. We have successfully brought the device into production with the Malaysian Institute for Micro-electronics Systems and initiated sales with significant cost and performance advantages over competing devices."
Zecotek's proprietary and patented MAPDs have been designed in several configurations to offer significant cost and performance advantages over the current vacuum tube based photo multiplier tubes (PMT) and other solid-state photo diodes. Zecotek's MAPD-2 addresses specific, high-demand requirements in high-energy physics such as particle accelerators where PMTs are vulnerable to the magnetic environment created by the superconducting magnets used in the collimation of particle tracks. The MAPD-3 meets required specifications for advanced, high resolution PET (positron emission tomography) scanners and gamma camera applications, particularly when matched with Zecotek's patented LFS scintillation materials. Photo detectors, together with the scintillation material, typically constitute 50 to 65% of the manufacturing cost of a PET scanner.
Existing photo multiplier tubes are also key components of medical inspection devices used in blood analysis and DNA sequencing. Additional non-medical applications include: gamma ray detectors for homeland security, environmental monitoring, industrial control systems, robotics, biomedical testing, navigation and guidance systems, laser radars and high-energy physics.
Zecotek's MAPD solid-state photo detectors are supplied through its wholly owned subsidiary Zecotek Imaging Systems Pte. Ltd., Singapore, and manufactured under contract by the Malaysian Institute of Microelectronic Systems. Technical specifications of the MAPD can be found on the company's website www.zecotek.com.
Zecotek Receives Russian Patent for MAPD Solid-State Photo Detectors; U.S. and PCT Patents Pending
VANCOUVER, British Columbia, March 28, 2008 (PRIME NEWSWIRE) -- Zecotek Photonics Inc. (TSX-V:ZMS) (Frankfurt:W1I) today announced that it has been granted full patent rights for its latest Micro-channel Avalanche Photodiode solid-state photo detector by the Agency for Intellectual Property Protection in Russia. Zecotek currently has pending U.S. and PCT (Patent Cooperation Treaty) counterpart applications for worldwide patent rights and anticipates approvals.
"Russia is acknowledged as the leader in the field of photo detection and the granting of Russian patent rights fully endorses the technological breakthroughs we have achieved," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. "Of equal importance is the demonstration of the MAPD's commercial viability. We have successfully brought the device into production with the Malaysian Institute for Micro-electronics Systems and initiated sales with significant cost and performance advantages over competing devices."
Zecotek's proprietary and patented MAPDs have been designed in several configurations to offer significant cost and performance advantages over the current vacuum tube based photo multiplier tubes (PMT) and other solid-state photo diodes. Zecotek's MAPD-2 addresses specific, high-demand requirements in high-energy physics such as particle accelerators where PMTs are vulnerable to the magnetic environment created by the superconducting magnets used in the collimation of particle tracks. The MAPD-3 meets required specifications for advanced, high resolution PET (positron emission tomography) scanners and gamma camera applications, particularly when matched with Zecotek's patented LFS scintillation materials. Photo detectors, together with the scintillation material, typically constitute 50 to 65% of the manufacturing cost of a PET scanner.
Existing photo multiplier tubes are also key components of medical inspection devices used in blood analysis and DNA sequencing. Additional non-medical applications include: gamma ray detectors for homeland security, environmental monitoring, industrial control systems, robotics, biomedical testing, navigation and guidance systems, laser radars and high-energy physics.
Zecotek's MAPD solid-state photo detectors are supplied through its wholly owned subsidiary Zecotek Imaging Systems Pte. Ltd., Singapore, and manufactured under contract by the Malaysian Institute of Microelectronic Systems. Technical specifications of the MAPD can be found on the company's website www.zecotek.com.
Antwort auf Beitrag Nr.: 33.853.191 von Mick1968 am 10.04.08 08:44:34Zecotek Photonics Inc.
TSX VENTURE: ZMS
FRANKFURT: W1I
Apr 24, 2008 03:00 ETZecotek Granted Australian Patent for 3D2D Display System
VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 24, 2008) - Zecotek Photonics Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I) is pleased to announce that it has been granted acceptance by the Australian Commissioner of Patents for its Real-Time 3D2D Display System technology. Australian Patent Number 2006200812 provides patent protection for 3 dimensional stereoscopic display systems.
"This is a very important step in the development of our 3D display technology as it is recognition that our system is innovative and that our intellectual property can be protected," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. "We have approached the challenge of 3D visualization from a completely different direction. Existing 3D displays have significant deficiencies or require viewers to wear special glasses. Our Real-Time 3D2D Display System is the only 3D system that provides multiple viewers with a true three dimensional picture, offering both depth and volume in high resolution over a wide viewing angle."
In November 2007, Zecotek initiated demonstrations, of the 32" commercial prototype of its proprietary and now patented 3D display system, for a select group of representatives of potential industry partners. The Company is also working with Insight Media, a leading publishing and consulting firm focused on the display industry, to finalize a market entry strategy for the 3D display system.
Zecotek's Real-Time 3D2D Display System is a novel, patented display system for images and data and represents a new generation of 3D displays. The 32" commercial prototype is described as multi-user/multi-view with continuous 3D within the viewing angle. With substantial patented innovation, the 3D display delivers full colour, high resolution images in both 3D and 2D mode (greater than 1024x768), has high definition quality images in 2D mode and is compatible with existing rear projection television components. Anteryon BV of the Netherlands manufactures the key screen component of the 3D display.
With its innovative technology, continuous 3D and high resolution, Zecotek's 3D display technology has attracted great interest from a variety of end users for applications in education, computer generated games, advertising, medical imaging, medical training and air traffic control.
About Zecotek
Zecotek Photonics Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I) is a photonics technology company developing leading-edge products: crystals, photo detectors, lasers, imaging and 3D display technologies, for medical, biotech, industrial, nanotech and atomic/molecular science applications. Founded in 2003, the company has three distinct operating divisions: Laser Systems, Imaging Systems and 3D Display Systems and labs located in Canada, the United States, Singapore, Malaysia and Russia. Zecotek commercializes its novel, patented and patent-pending photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders. For more information, please visit www.zecotek.com.
This press release may contain forward-looking statements that are based on management's expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
For more information, please contact
Zecotek Photonics Inc. - Product and Technical Information
Susana Mendez Alcala
(604) 827-5232
Email: SMA@zecotek.com
or
Zecotek Photonics Inc. - Corporate Information
Michael Minder
CFO; VP Corporate Development
(604) 827-5203
Website: www.zecotek.com
or
Caliber Capital & Communications - Investor Information
Tim McNulty
(778) 327-6678
Email: ir@zecotek.com
TSX VENTURE: ZMS
FRANKFURT: W1I
Apr 24, 2008 03:00 ETZecotek Granted Australian Patent for 3D2D Display System
VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 24, 2008) - Zecotek Photonics Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I) is pleased to announce that it has been granted acceptance by the Australian Commissioner of Patents for its Real-Time 3D2D Display System technology. Australian Patent Number 2006200812 provides patent protection for 3 dimensional stereoscopic display systems.
"This is a very important step in the development of our 3D display technology as it is recognition that our system is innovative and that our intellectual property can be protected," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. "We have approached the challenge of 3D visualization from a completely different direction. Existing 3D displays have significant deficiencies or require viewers to wear special glasses. Our Real-Time 3D2D Display System is the only 3D system that provides multiple viewers with a true three dimensional picture, offering both depth and volume in high resolution over a wide viewing angle."
In November 2007, Zecotek initiated demonstrations, of the 32" commercial prototype of its proprietary and now patented 3D display system, for a select group of representatives of potential industry partners. The Company is also working with Insight Media, a leading publishing and consulting firm focused on the display industry, to finalize a market entry strategy for the 3D display system.
Zecotek's Real-Time 3D2D Display System is a novel, patented display system for images and data and represents a new generation of 3D displays. The 32" commercial prototype is described as multi-user/multi-view with continuous 3D within the viewing angle. With substantial patented innovation, the 3D display delivers full colour, high resolution images in both 3D and 2D mode (greater than 1024x768), has high definition quality images in 2D mode and is compatible with existing rear projection television components. Anteryon BV of the Netherlands manufactures the key screen component of the 3D display.
With its innovative technology, continuous 3D and high resolution, Zecotek's 3D display technology has attracted great interest from a variety of end users for applications in education, computer generated games, advertising, medical imaging, medical training and air traffic control.
About Zecotek
Zecotek Photonics Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I) is a photonics technology company developing leading-edge products: crystals, photo detectors, lasers, imaging and 3D display technologies, for medical, biotech, industrial, nanotech and atomic/molecular science applications. Founded in 2003, the company has three distinct operating divisions: Laser Systems, Imaging Systems and 3D Display Systems and labs located in Canada, the United States, Singapore, Malaysia and Russia. Zecotek commercializes its novel, patented and patent-pending photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders. For more information, please visit www.zecotek.com.
This press release may contain forward-looking statements that are based on management's expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
For more information, please contact
Zecotek Photonics Inc. - Product and Technical Information
Susana Mendez Alcala
(604) 827-5232
Email: SMA@zecotek.com
or
Zecotek Photonics Inc. - Corporate Information
Michael Minder
CFO; VP Corporate Development
(604) 827-5203
Website: www.zecotek.com
or
Caliber Capital & Communications - Investor Information
Tim McNulty
(778) 327-6678
Email: ir@zecotek.com
Antwort auf Beitrag Nr.: 33.853.157 von Mick1968 am 10.04.08 08:41:0964 Chip Photo Detector Array Announced
April 16, 2008
Zecotek Expands MAPD Photo Detection Line; Introduces 64 Chip Photo Detector Array
VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 16, 2008) - Zecotek Photonics Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I) is pleased to announce that it has successfully completed pre-production testing of a new, proprietary array of Micro-pixel Avalanche Photodiodes (MAPD). The MAPD Array integrates Zecotek's patented MAPD technologies and will be initially produced in an 8 by 8 format, with 64 individual MAPDs each measuring 3mm by 3mm, and scalable to larger dimensions. First run production has been slated for evaluation by select industry partners.
"Our 64 chip MAPD Array has been specifically designed for use with our LFS scintillation crystals in medical scanning applications," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. "Their unique performance and design attributes provide a significant opportunity for new detection configurations which allow for higher resolution, more conclusive medical interpretation of data and images, and new applications in Positron Emission Tomography. In addition, the Array has a wide range of applications in high-energy physics, security and other imaging industries. We are delighted with the strong interest and support we are receiving from key industry players."
Zecotek's proprietary and patented MAPDs have been designed in several configurations to offer significant cost and performance advantages over existing vacuum tube based photo multiplier tubes (PMT) and other solid-state photodiodes. A key advantage of the MAPD Array is the ability to provide uniform quantum efficiency and high gain across the entire array, using a single supply voltage. This vastly simplifies signal read-out and processing of data, particularly important features for applications in Positron Emission Tomography (PET) based medical diagnosis and in high-energy physics. The MAPD Array integrates Zecotek's patented MAPD which meets and exceeds required specifications for advanced, high resolution PET scanners, particularly when matched with Zecotek's patented LFS scintillation materials. Photo detectors, together with the scintillation material, typically constitute 50 to 65% of the manufacturing cost of a PET scanner.
Existing photo multiplier tubes markets where Zecotek's MAPDs offer both cost and performance advantages include medical inspection devices used in blood analysis and DNA sequencing, gamma ray detectors for homeland security, environmental monitoring, industrial control systems, robotics, biomedical testing, navigation and guidance systems, laser radars and high-energy physics.
Zecotek's MAPD solid-state photo detectors and photo detector arrays are supplied through its wholly owned subsidiary Zecotek Imaging Systems Pte. Ltd., Singapore, and manufactured under contract by the Malaysian Institute of Microelectronic Systems.
April 16, 2008
Zecotek Expands MAPD Photo Detection Line; Introduces 64 Chip Photo Detector Array
VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 16, 2008) - Zecotek Photonics Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I) is pleased to announce that it has successfully completed pre-production testing of a new, proprietary array of Micro-pixel Avalanche Photodiodes (MAPD). The MAPD Array integrates Zecotek's patented MAPD technologies and will be initially produced in an 8 by 8 format, with 64 individual MAPDs each measuring 3mm by 3mm, and scalable to larger dimensions. First run production has been slated for evaluation by select industry partners.
"Our 64 chip MAPD Array has been specifically designed for use with our LFS scintillation crystals in medical scanning applications," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. "Their unique performance and design attributes provide a significant opportunity for new detection configurations which allow for higher resolution, more conclusive medical interpretation of data and images, and new applications in Positron Emission Tomography. In addition, the Array has a wide range of applications in high-energy physics, security and other imaging industries. We are delighted with the strong interest and support we are receiving from key industry players."
Zecotek's proprietary and patented MAPDs have been designed in several configurations to offer significant cost and performance advantages over existing vacuum tube based photo multiplier tubes (PMT) and other solid-state photodiodes. A key advantage of the MAPD Array is the ability to provide uniform quantum efficiency and high gain across the entire array, using a single supply voltage. This vastly simplifies signal read-out and processing of data, particularly important features for applications in Positron Emission Tomography (PET) based medical diagnosis and in high-energy physics. The MAPD Array integrates Zecotek's patented MAPD which meets and exceeds required specifications for advanced, high resolution PET scanners, particularly when matched with Zecotek's patented LFS scintillation materials. Photo detectors, together with the scintillation material, typically constitute 50 to 65% of the manufacturing cost of a PET scanner.
Existing photo multiplier tubes markets where Zecotek's MAPDs offer both cost and performance advantages include medical inspection devices used in blood analysis and DNA sequencing, gamma ray detectors for homeland security, environmental monitoring, industrial control systems, robotics, biomedical testing, navigation and guidance systems, laser radars and high-energy physics.
Zecotek's MAPD solid-state photo detectors and photo detector arrays are supplied through its wholly owned subsidiary Zecotek Imaging Systems Pte. Ltd., Singapore, and manufactured under contract by the Malaysian Institute of Microelectronic Systems.
IRW-PRESS: Zecotek Photonics Inc.: Zecotek erwirbt australisches Patent für sein 3D2D-Darstellungssystem
Zecotek erwirbt australisches Patent für sein 3D2D-Darstellungssystem
Vancouver, BC, 24. April 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) freut sich bekannt zu geben, dass die Patentanmeldung bezüglich seiner Echtzeit-3D2D-Darstellungssystemtechnologie vom Australian Commissioner of Patents genehmigt wurde. Die australische Patentnummer 2006200812 bietet dreidimensionalen stereoskopen Darstellungssystemen einen Patentschutz.
Das ist ein äußerst wichtiger Schritt bei der Entwicklung unserer 3D-Darstellungstechnologie, da dies eine Anerkennung für die Innovation unseres Systems darstellt, welches nun als unser geistiges Eigentum geschützt ist, sagte Dr. A.F. Zerrouk, Chairman, President und CEO von Zecotek. Wir haben uns der Herausforderung der 3D-Darstellung mit einem vollkommen neuen Ansatz gestellt. Bisherige 3D-Anzeigen weisen beträchtliche Schwächen auf oder setzen voraus, dass der Betrachter eine spezielle Brille trägt. Unser Echtzeit-3D2D-Darstellungssystem ist das einzige 3D-System, das mehreren Betrachtern gleichzeitig ein echtes 3D-Bild ermöglicht und dabei eine hochauflösende räumliche Wahrnehmung aus einem breiten Blickwinkel bietet.
Im November 2007 begann Zecotek mit den Demonstrationen des kommerziellen 32-Prototyps seines eigenen und nunmehr patentierten 3D-Darstellungssystems vor einer ausgewählten Gruppe von Vertretern potenzieller Geschäftspartner. Das Unternehmen arbeitet auch mit Insight Media zusammen, einem führenden Verlags- und Beratungsunternehmen, dessen Hauptaugenmerk auf der Darstellungsbranche liegt, um eine Strategie zur Markteinführung des 3D-Darstellungssystems zu planen.
Das Echtzeit-3D2D-Darstellungssystem von Zecotek ist ein neuartiges, patentiertes Darstellungssystem für Bilder und Daten und stellt eine neue Generation der 3D-Anzeige dar. Der kommerzielle 32-Prototyp wird als Multiuser/Multiansicht mit beständiger 3D-Anzeige innerhalb des Blickwinkels beschrieben. Dank ihrer patentierten Innovation bietet die 3D-Darstellung sowohl im 3D- als auch im 2D-Modus hochauflösende Farbbilder (über 1024x768), weist eine hochauflösende Bildqualität im 2D-Modus auf und ist zudem mit bestehenden Rückprojektions-TV-Komponenten kompatibel. Anteryon BV aus den Niederlanden stellt die wichtigste Bildschirmkomponente der 3D-Darstellung her.
Mit seiner innovativen Technologie, einer beständigen 3D-Anzeige und der hohen Auflösung zog die 3D2D-Technologie von Zecotek die Aufmerksamkeit zahlreicher Endbenutzer für Anwendungen im Bildungs-, Videospiel-, Werbe-, medizinischen Darstellungs-, medizinischen Trainings- und Luftüberwachungsbereich auf sich.
Über Zecotek
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) ist ein Photonik-Technologieunternehmen, das moderne Produkte entwickelt: Kristalle, Photodetektoren, Laser, Bildverarbeitungs- und 3D-Darstellungstechnologien für medizinische, biotechnische, industrielle, nanotechnische und atomare/molekulare wissenschaftliche Anwendungen. Das im Jahr 2003 gegründete Unternehmen ist in drei unterschiedlichen Bereichen tätig: Lasersysteme, Bildverarbeitungssysteme und 3D-Darstellungssysteme. Die Niederlassungen des Unternehmens befinden sich in Kanada, USA, Singapur, Malaysia und Russland. Zecotek vermarktet seine neuartigen, patentierten und zum Patent angemeldeten Photonik-Technologien direkt und mittels strategischer Allianzen und Jointventures mit multinationalen OEMs an Händler und andere Marktführer der Branche. Für weitere Informationen können Sie uns im Internet besuchen: www.zecotek.com
Diese Pressemitteilung könnte vorausblickende Aussagen enthalten, die auf den Erwartungen, Schätzungen, Plänen und Annahmen des Managements basieren. Diese Aussagen sind keine Garantie für zukünftige Leistungen und beinhalten bestimmte Risiken und Ungewissheiten, welche nur schwer vorhersehbar sind. Daher können sich tatsächliche zukünftige Ergebnisse und Trends erheblich von jenen unterscheiden, die in solchen Aussagen zum Ausdruck gebracht wurden.
Für technische und produktspezifische Informationen kontaktieren Sie bitte:
Zecotek Photonics Inc.
SUSANA MENDEZ ALCALA
SMA@zecotek.com
Tel: (604) 827-5232
Für Informationen über das Unternehmen kontaktieren Sie bitte:
Zecotek Photonics Inc.
MICHAEL MINDER
CFO; VP Corporate Development
Tel: (604) 827-5203
Für Investment-Informationen kontaktieren Sie bitte:
Caliber Capital & Communications
TIM MCNULTY
Tel: (778) 327-6678
E-Mail: ir@zecotek.com
Die TSX Venture Exchange hat diese Pressemitteilung nicht überprüft und übernimmt keine Verantwortung für die Richtigkeit oder Genauigkeit des Inhaltes derselben.
Wenn Sie in Zukunft über Neuigkeiten von Zecotek informiert werden möchten, besuchen Sie bitte unsere Website unter www.zecotek.com
Für die Richtigkeit der Übersetzung wird keine Haftung übernommen! Bitte englische Originalmeldung beachten!
Die englische Originalmeldung finden Sie unter:
[http://www.irw-press.at/press_html.aspx?messageID=11178]
Autor: dpa-AFX
Zecotek erwirbt australisches Patent für sein 3D2D-Darstellungssystem
Vancouver, BC, 24. April 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) freut sich bekannt zu geben, dass die Patentanmeldung bezüglich seiner Echtzeit-3D2D-Darstellungssystemtechnologie vom Australian Commissioner of Patents genehmigt wurde. Die australische Patentnummer 2006200812 bietet dreidimensionalen stereoskopen Darstellungssystemen einen Patentschutz.
Das ist ein äußerst wichtiger Schritt bei der Entwicklung unserer 3D-Darstellungstechnologie, da dies eine Anerkennung für die Innovation unseres Systems darstellt, welches nun als unser geistiges Eigentum geschützt ist, sagte Dr. A.F. Zerrouk, Chairman, President und CEO von Zecotek. Wir haben uns der Herausforderung der 3D-Darstellung mit einem vollkommen neuen Ansatz gestellt. Bisherige 3D-Anzeigen weisen beträchtliche Schwächen auf oder setzen voraus, dass der Betrachter eine spezielle Brille trägt. Unser Echtzeit-3D2D-Darstellungssystem ist das einzige 3D-System, das mehreren Betrachtern gleichzeitig ein echtes 3D-Bild ermöglicht und dabei eine hochauflösende räumliche Wahrnehmung aus einem breiten Blickwinkel bietet.
Im November 2007 begann Zecotek mit den Demonstrationen des kommerziellen 32-Prototyps seines eigenen und nunmehr patentierten 3D-Darstellungssystems vor einer ausgewählten Gruppe von Vertretern potenzieller Geschäftspartner. Das Unternehmen arbeitet auch mit Insight Media zusammen, einem führenden Verlags- und Beratungsunternehmen, dessen Hauptaugenmerk auf der Darstellungsbranche liegt, um eine Strategie zur Markteinführung des 3D-Darstellungssystems zu planen.
Das Echtzeit-3D2D-Darstellungssystem von Zecotek ist ein neuartiges, patentiertes Darstellungssystem für Bilder und Daten und stellt eine neue Generation der 3D-Anzeige dar. Der kommerzielle 32-Prototyp wird als Multiuser/Multiansicht mit beständiger 3D-Anzeige innerhalb des Blickwinkels beschrieben. Dank ihrer patentierten Innovation bietet die 3D-Darstellung sowohl im 3D- als auch im 2D-Modus hochauflösende Farbbilder (über 1024x768), weist eine hochauflösende Bildqualität im 2D-Modus auf und ist zudem mit bestehenden Rückprojektions-TV-Komponenten kompatibel. Anteryon BV aus den Niederlanden stellt die wichtigste Bildschirmkomponente der 3D-Darstellung her.
Mit seiner innovativen Technologie, einer beständigen 3D-Anzeige und der hohen Auflösung zog die 3D2D-Technologie von Zecotek die Aufmerksamkeit zahlreicher Endbenutzer für Anwendungen im Bildungs-, Videospiel-, Werbe-, medizinischen Darstellungs-, medizinischen Trainings- und Luftüberwachungsbereich auf sich.
Über Zecotek
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) ist ein Photonik-Technologieunternehmen, das moderne Produkte entwickelt: Kristalle, Photodetektoren, Laser, Bildverarbeitungs- und 3D-Darstellungstechnologien für medizinische, biotechnische, industrielle, nanotechnische und atomare/molekulare wissenschaftliche Anwendungen. Das im Jahr 2003 gegründete Unternehmen ist in drei unterschiedlichen Bereichen tätig: Lasersysteme, Bildverarbeitungssysteme und 3D-Darstellungssysteme. Die Niederlassungen des Unternehmens befinden sich in Kanada, USA, Singapur, Malaysia und Russland. Zecotek vermarktet seine neuartigen, patentierten und zum Patent angemeldeten Photonik-Technologien direkt und mittels strategischer Allianzen und Jointventures mit multinationalen OEMs an Händler und andere Marktführer der Branche. Für weitere Informationen können Sie uns im Internet besuchen: www.zecotek.com
Diese Pressemitteilung könnte vorausblickende Aussagen enthalten, die auf den Erwartungen, Schätzungen, Plänen und Annahmen des Managements basieren. Diese Aussagen sind keine Garantie für zukünftige Leistungen und beinhalten bestimmte Risiken und Ungewissheiten, welche nur schwer vorhersehbar sind. Daher können sich tatsächliche zukünftige Ergebnisse und Trends erheblich von jenen unterscheiden, die in solchen Aussagen zum Ausdruck gebracht wurden.
Für technische und produktspezifische Informationen kontaktieren Sie bitte:
Zecotek Photonics Inc.
SUSANA MENDEZ ALCALA
SMA@zecotek.com
Tel: (604) 827-5232
Für Informationen über das Unternehmen kontaktieren Sie bitte:
Zecotek Photonics Inc.
MICHAEL MINDER
CFO; VP Corporate Development
Tel: (604) 827-5203
Für Investment-Informationen kontaktieren Sie bitte:
Caliber Capital & Communications
TIM MCNULTY
Tel: (778) 327-6678
E-Mail: ir@zecotek.com
Die TSX Venture Exchange hat diese Pressemitteilung nicht überprüft und übernimmt keine Verantwortung für die Richtigkeit oder Genauigkeit des Inhaltes derselben.
Wenn Sie in Zukunft über Neuigkeiten von Zecotek informiert werden möchten, besuchen Sie bitte unsere Website unter www.zecotek.com
Für die Richtigkeit der Übersetzung wird keine Haftung übernommen! Bitte englische Originalmeldung beachten!
Die englische Originalmeldung finden Sie unter:
[http://www.irw-press.at/press_html.aspx?messageID=11178]
Autor: dpa-AFX
IRW-News: Zecotek Photonics Inc.
IRW-PRESS: Zecotek Photonics Inc.: Zecotek nimmt an Conference on Lasers and Electro-Optics in San Jose, Kalifornien, teil
Zecotek nimmt an Conference on Lasers and Electro-Optics in San Jose, Kalifornien, teil
Vancouver, 29.
April 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) meldete heute, dass es bei der Conference on Lasers and Electro-Optics, die von 6. bis 9. Mai 2008 im San Jose McEnery Convention Center in San Jose, Kalifornien, stattfinden wird, ausgewählte Darstellungs- und Laserprodukte präsentieren wird.
Zecotek wird seine bahnbrechende Technologie vor Institutionen und Unternehmen demonstrieren, die auf den globalen Photonen- und Optikmärkten aktiv sind. Im Mittelpunkt steht dabei die Produktreihe der 540 nm und 550 nm Green Fiber Lasers des Unternehmens, die in den Wellenlängen des grünen Spektralbereichs arbeiten und unmittelbare Anwendungen in der Genomforschung, in der Durchflusscytometrie und in der konfokalen Mikroskopie bieten. Zecotek wird auch andere hochmoderne Produkte vorstellen, wie etwa den RFO-Vanadat-Laser sowie die patentierten LFS-Szintillationskristalle und die eigenen MAPD-Festkörper-Photodetektoren, die in der medizinischen Diagnostik und anderen nicht medizinischen Darstellungen verwendet werden. Zecotek lädt alle Teilnehmer herzlich ein, sich bei Stand 1937 über die bahnbrechenden Produkte des Unternehmens zu informieren.
Die Conference on Lasers and Electro-Optics und die Quantum Electronics and Laser Science Conference (CLEO/QELS) vereint auf erfolgreiche Weise die wissenschaftlichen und praktischen Aspekte der Optik- und Photonenbranche. Die Konferenzen kombinieren die Stärke eines von Experten geprüften wissenschaftlichen Programms mit einer anwendungsorientierten Präsentation, um die Gegenwart und die Zukunft dieser Technologie zu demonstrieren. CLEO/QELS stellt ein Bildungsforum dar, bei dem Schnellkurse, Übungen, Workshops, usw. angeboten werden. Die Themen sind so unterschiedlich wie das breit gefächerte Spektrum der Teilnehmer: von Biomedizin über Verteidigung bis hin zu Optik. Weitere Informationen erhalten Sie hier: www.cleoconference.org.
Über Zecotek
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) ist ein Photonik-Technologieunternehmen, das moderne Produkte entwickelt: Kristalle, Photodetektoren, Laser, Bildverarbeitungs- und 3D-Darstellungstechnologien für medizinische, biotechnische, industrielle, nanotechnische und atomare/molekulare wissenschaftliche Anwendungen. Das im Jahr 2003 gegründete Unternehmen ist in drei unterschiedlichen Bereichen tätig: Lasersysteme, Bildverarbeitungssysteme und 3D-Darstellungssysteme. Die Niederlassungen des Unternehmens befinden sich in Kanada, USA, Singapur, Malaysia und Russland. Zecotek vermarktet seine neuartigen, patentierten und zum Patent angemeldeten Photonik-Technologien direkt und mittels strategischer Allianzen und Jointventures mit multinationalen OEMs an Händler und andere Marktführer der Branche. Für weitere Informationen können Sie uns im Internet besuchen: www.zecotek.com
Diese Pressemitteilung könnte vorausblickende Aussagen enthalten, die auf den Erwartungen, Schätzungen, Plänen und Annahmen des Managements basieren. Diese Aussagen sind keine Garantie für zukünftige Leistungen und beinhalten bestimmte Risiken und Ungewissheiten, welche nur schwer vorhersehbar sind. Daher können sich tatsächliche zukünftige Ergebnisse und Trends erheblich von jenen unterscheiden, die in solchen Aussagen zum Ausdruck gebracht wurden.
Für technische und produktspezifische Informationen kontaktieren Sie bitte:
Zecotek Photonics Inc.
SUSANA MENDEZ ALCALA
SMA@zecotek.com
Tel: (604) 827-5232
Für Informationen über das Unternehmen kontaktieren Sie bitte:
Zecotek Photonics Inc.
MICHAEL MINDER
CFO; VP Corporate Development
Tel: (604) 827-5203
Für Investment-Informationen kontaktieren Sie bitte:
Caliber Capital & Communications
TIM MCNULTY
Tel: (778) 327-6678
E-Mail: ir@zecotek.com
Für die Richtigkeit der Übersetzung wird keine Haftung übernommen! Bitte englische Originalmeldung beachten!
Die englische Originalmeldung finden Sie unter:
[http://www.irw-press.at/press_html.aspx?messageID=11236]
Quelle: dpa-AFX
IRW-PRESS: Zecotek Photonics Inc.: Zecotek nimmt an Conference on Lasers and Electro-Optics in San Jose, Kalifornien, teil
Zecotek nimmt an Conference on Lasers and Electro-Optics in San Jose, Kalifornien, teil
Vancouver, 29.
April 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) meldete heute, dass es bei der Conference on Lasers and Electro-Optics, die von 6. bis 9. Mai 2008 im San Jose McEnery Convention Center in San Jose, Kalifornien, stattfinden wird, ausgewählte Darstellungs- und Laserprodukte präsentieren wird.
Zecotek wird seine bahnbrechende Technologie vor Institutionen und Unternehmen demonstrieren, die auf den globalen Photonen- und Optikmärkten aktiv sind. Im Mittelpunkt steht dabei die Produktreihe der 540 nm und 550 nm Green Fiber Lasers des Unternehmens, die in den Wellenlängen des grünen Spektralbereichs arbeiten und unmittelbare Anwendungen in der Genomforschung, in der Durchflusscytometrie und in der konfokalen Mikroskopie bieten. Zecotek wird auch andere hochmoderne Produkte vorstellen, wie etwa den RFO-Vanadat-Laser sowie die patentierten LFS-Szintillationskristalle und die eigenen MAPD-Festkörper-Photodetektoren, die in der medizinischen Diagnostik und anderen nicht medizinischen Darstellungen verwendet werden. Zecotek lädt alle Teilnehmer herzlich ein, sich bei Stand 1937 über die bahnbrechenden Produkte des Unternehmens zu informieren.
Die Conference on Lasers and Electro-Optics und die Quantum Electronics and Laser Science Conference (CLEO/QELS) vereint auf erfolgreiche Weise die wissenschaftlichen und praktischen Aspekte der Optik- und Photonenbranche. Die Konferenzen kombinieren die Stärke eines von Experten geprüften wissenschaftlichen Programms mit einer anwendungsorientierten Präsentation, um die Gegenwart und die Zukunft dieser Technologie zu demonstrieren. CLEO/QELS stellt ein Bildungsforum dar, bei dem Schnellkurse, Übungen, Workshops, usw. angeboten werden. Die Themen sind so unterschiedlich wie das breit gefächerte Spektrum der Teilnehmer: von Biomedizin über Verteidigung bis hin zu Optik. Weitere Informationen erhalten Sie hier: www.cleoconference.org.
Über Zecotek
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) ist ein Photonik-Technologieunternehmen, das moderne Produkte entwickelt: Kristalle, Photodetektoren, Laser, Bildverarbeitungs- und 3D-Darstellungstechnologien für medizinische, biotechnische, industrielle, nanotechnische und atomare/molekulare wissenschaftliche Anwendungen. Das im Jahr 2003 gegründete Unternehmen ist in drei unterschiedlichen Bereichen tätig: Lasersysteme, Bildverarbeitungssysteme und 3D-Darstellungssysteme. Die Niederlassungen des Unternehmens befinden sich in Kanada, USA, Singapur, Malaysia und Russland. Zecotek vermarktet seine neuartigen, patentierten und zum Patent angemeldeten Photonik-Technologien direkt und mittels strategischer Allianzen und Jointventures mit multinationalen OEMs an Händler und andere Marktführer der Branche. Für weitere Informationen können Sie uns im Internet besuchen: www.zecotek.com
Diese Pressemitteilung könnte vorausblickende Aussagen enthalten, die auf den Erwartungen, Schätzungen, Plänen und Annahmen des Managements basieren. Diese Aussagen sind keine Garantie für zukünftige Leistungen und beinhalten bestimmte Risiken und Ungewissheiten, welche nur schwer vorhersehbar sind. Daher können sich tatsächliche zukünftige Ergebnisse und Trends erheblich von jenen unterscheiden, die in solchen Aussagen zum Ausdruck gebracht wurden.
Für technische und produktspezifische Informationen kontaktieren Sie bitte:
Zecotek Photonics Inc.
SUSANA MENDEZ ALCALA
SMA@zecotek.com
Tel: (604) 827-5232
Für Informationen über das Unternehmen kontaktieren Sie bitte:
Zecotek Photonics Inc.
MICHAEL MINDER
CFO; VP Corporate Development
Tel: (604) 827-5203
Für Investment-Informationen kontaktieren Sie bitte:
Caliber Capital & Communications
TIM MCNULTY
Tel: (778) 327-6678
E-Mail: ir@zecotek.com
Für die Richtigkeit der Übersetzung wird keine Haftung übernommen! Bitte englische Originalmeldung beachten!
Die englische Originalmeldung finden Sie unter:
[http://www.irw-press.at/press_html.aspx?messageID=11236]
Quelle: dpa-AFX
Antwort auf Beitrag Nr.: 33.853.157 von Mick1968 am 10.04.08 08:41:09Vielleicht sollten die "Verunsicherten" einfach diesen Thread einmal durchstöbern, um sich zu versichern, was ZMS bereits alles geleistet hat.
Zecotek Appoints Major Distributor
May 27, 2008
Zecotek Signs Agreement with Major Distributor For its Products in Israel
Vancouver, BC, May 27, 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) is pleased to announce that it has signed an exclusive sales and distribution agreement with Toyo Ram for Zecotek products in Israel.
“We are very pleased to have engaged Toyo Ram for sales and distribution of our products into Israel’s medical imaging and expanding photonics markets” said Dr. F. Zerrouk, Chairman, President and CEO of Zecotek Photonics. “Their extensive customer base and excellent relationships promise to significantly contribute to our sales revenues. Israel’s medical imaging and bio-tech sectors are growing rapidly and make up a significant portion of global market in these areas.”
The agreement covers Zecotek’s broad portfolio of photonic technologies: proprietary Green Fiber and Ultra-wide tunable lasers, solid-state MAPD photo detectors combined with the LFS scintillation material, and RFO vanadate laser crystals. The agreement will be managed through Zecotek’s Singapore subsidiaries, Zecotek Laser Systems Pte. Ltd. and Zecotek Imaging Systems Pte. Ltd. on a product basis.
Toyo Ram represents a number of top-tier international manufacturers and providers, including Novatel and Top Global, and is rated as one of Israel’s top distributors and integrators for systems, subsystems and components to a broad spectrum of industries. Their extensive customer base include scientific organizations; government agencies; telco, cellular, CATV and satellite providers; and other enterprise and system companies. For more information on Toyo Ram please visit their website at www.toyoram.co.il
About Zecotek
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing leading-edge products: crystals, photo detectors, lasers, imaging and 3D display technologies, for medical, biotech, industrial, nanotech and atomic/molecular science applications. Founded in 2003, the company has three distinct operating divisions: Laser Systems, Imaging Systems and 3D Display Systems and labs located in Canada, the United States, Singapore, Malaysia and Russia. Zecotek commercializes its novel, patented and patent-pending photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders. For more information, please visit www.zecotek.com.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For product and technical information please contact:
Zecotek Photonics Inc., SUSANA MENDEZ ALCALA, SMA@zecotek.com, T: (604) 827-5232
For corporate information please contact:
Zecotek Photonics Inc., MICHAEL MINDER, CFO; VP Corporate Development, T: (604) 827-5203
For investor information please contact:
Caliber Capital & Communications, TIM MCNULTY, T: (778) 327-6678, E: ir@zecotek.com
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
May 27, 2008
Zecotek Signs Agreement with Major Distributor For its Products in Israel
Vancouver, BC, May 27, 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) is pleased to announce that it has signed an exclusive sales and distribution agreement with Toyo Ram for Zecotek products in Israel.
“We are very pleased to have engaged Toyo Ram for sales and distribution of our products into Israel’s medical imaging and expanding photonics markets” said Dr. F. Zerrouk, Chairman, President and CEO of Zecotek Photonics. “Their extensive customer base and excellent relationships promise to significantly contribute to our sales revenues. Israel’s medical imaging and bio-tech sectors are growing rapidly and make up a significant portion of global market in these areas.”
The agreement covers Zecotek’s broad portfolio of photonic technologies: proprietary Green Fiber and Ultra-wide tunable lasers, solid-state MAPD photo detectors combined with the LFS scintillation material, and RFO vanadate laser crystals. The agreement will be managed through Zecotek’s Singapore subsidiaries, Zecotek Laser Systems Pte. Ltd. and Zecotek Imaging Systems Pte. Ltd. on a product basis.
Toyo Ram represents a number of top-tier international manufacturers and providers, including Novatel and Top Global, and is rated as one of Israel’s top distributors and integrators for systems, subsystems and components to a broad spectrum of industries. Their extensive customer base include scientific organizations; government agencies; telco, cellular, CATV and satellite providers; and other enterprise and system companies. For more information on Toyo Ram please visit their website at www.toyoram.co.il
About Zecotek
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing leading-edge products: crystals, photo detectors, lasers, imaging and 3D display technologies, for medical, biotech, industrial, nanotech and atomic/molecular science applications. Founded in 2003, the company has three distinct operating divisions: Laser Systems, Imaging Systems and 3D Display Systems and labs located in Canada, the United States, Singapore, Malaysia and Russia. Zecotek commercializes its novel, patented and patent-pending photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders. For more information, please visit www.zecotek.com.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For product and technical information please contact:
Zecotek Photonics Inc., SUSANA MENDEZ ALCALA, SMA@zecotek.com, T: (604) 827-5232
For corporate information please contact:
Zecotek Photonics Inc., MICHAEL MINDER, CFO; VP Corporate Development, T: (604) 827-5203
For investor information please contact:
Caliber Capital & Communications, TIM MCNULTY, T: (778) 327-6678, E: ir@zecotek.com
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
Antwort auf Beitrag Nr.: 34.659.807 von Piatti am 06.08.08 13:46:53Hat noch keiner herausgefunden was unter dem rot durchgestrichenen steht?
Ich hab mal eine email an LOM geschickt mit der Bitte, mir diesen report vom July 23 2008 zukommen zu lassen. Wenn die was mailen stell ich es hier rein.
Ich hab mal eine email an LOM geschickt mit der Bitte, mir diesen report vom July 23 2008 zukommen zu lassen. Wenn die was mailen stell ich es hier rein.
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
| Wertpapier | Perf. % |
|---|---|
| +0,18 | |
| +0,37 | |
| +5,88 | |
| -1,47 | |
| 0,00 | |
| -87,00 | |
| -1,06 | |
| -0,92 | |
| -3,70 | |
| -0,10 |
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 296 | ||
| 123 | ||
| 104 | ||
| 104 | ||
| 85 | ||
| 58 | ||
| 53 | ||
| 46 | ||
| 43 | ||
| 42 |
Zecotek Photonics Aufträge
